https://bioxlist.com/blogs/news/guide-to-biotech-funding-strategies-and-opportunities 2024-12-09T10:53:46+01:00 weekly https://bioxlist.com/blogs/news/how-to-contact-a-pharmaceutical-company-bd-team-for-partnering 2025-09-10T17:14:15+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/dna-163466_1280_a00b6a84-7a3c-4245-95ff-4589a0e417d8.jpg?v=1757517255 How to Contact a Pharmaceutical Company BD Team for Partnering https://bioxlist.com/blogs/news/why-investing-in-biotech-a-comprehensive-guide-to-opportunities-and-growth 2024-12-11T16:27:57+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/ashraful-islam-pRt3JVYlJho-unsplash.jpg?v=1733930849 Why Investing in Biotech: A Comprehensive Guide to Opportunities and Growth A high-resolution 3D render of a DNA double helix structure, symbolizing the cutting-edge biotechnology. https://bioxlist.com/blogs/news/unlocking-the-potential-of-biotech-a-guide-to-successful-investing 2024-12-12T16:43:19+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/national-cancer-institute-2fyeLhUeYpg-unsplash.jpg?v=1734018199 Unlocking the Potential of Biotech: A Guide to Successful Investing https://bioxlist.com/blogs/news/why-pharma-companies-seek-partnerships-with-biotechs 2025-09-10T17:15:35+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_6ef071a8-b289-4322-b0b4-2cfa1bb1db37.jpg?v=1757517335 Why Pharma Companies Seek Partnerships with Biotechs https://bioxlist.com/blogs/news/who-to-contact-for-biotech-venture-capital-funding-a-guide-to-understanding-vc-organization-and-targeting-the-right-person 2024-12-16T15:12:04+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/ben-o-bro-wpU4veNGnHg-unsplash.jpg?v=1734358102 Who to Contact for Biotech Venture Capital Funding? A Guide to Understanding VC Organization and Targeting the Right Person https://bioxlist.com/blogs/news/understanding-biotech-funding-how-much-do-they-raise 2024-12-19T12:28:48+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_1_520x500_520x500_f2152f8d-4d46-433f-b056-7686c3eaa1e1.jpg?v=1734607728 Understanding Biotech Funding: How Much Do They Raise? https://bioxlist.com/blogs/news/biotech-investment-strategy-a-comprehensive-guide-for-savvy-investors 2025-07-16T16:46:29+02:00 weekly https://bioxlist.com/blogs/news/breaking-into-biotech-venture-capital-a-guide-to-success 2025-07-16T15:41:26+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/evan-thomas-OcDfFpdW93c-unsplash_cd75e814-aa17-4b2c-9111-59b35b13e79b.jpg?v=1752673286 Breaking into Biotech Venture Capital: A Guide to Success https://bioxlist.com/blogs/news/what-sets-biotech-vc-apart-from-other-venture-capital-sectors 2024-12-20T11:13:36+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_c2db136c-e687-416d-9489-52e34290b72f.jpg?v=1734689609 What Sets Biotech VC Apart from Other Venture Capital Sectors https://bioxlist.com/blogs/news/unlocking-startup-growth-the-essential-role-of-biotech-venture-support 2024-12-23T22:35:19+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_80bc872e-f22e-4b60-b2ec-2a007b068a96.jpg?v=1734946402 Unlocking Startup Growth: The Essential Role of Biotech Venture Support https://bioxlist.com/blogs/news/understanding-biotech-seed-funding-what-founders-need-to-know 2025-07-16T16:07:32+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/dna-8829661_1280_9500f4f3-30cd-4814-bf78-3ae8d762c906.jpg?v=1752674852 Understanding Biotech Seed Funding: What Founders Need to Know https://bioxlist.com/blogs/news/securing-biotech-series-a-funding-strategies-for-scaling-your-startup 2025-07-16T15:45:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_788a1675-02c8-4a78-8d65-68ea41da13c8.jpg?v=1752673555 Securing Biotech Series A Funding: Strategies for Scaling Your Startup https://bioxlist.com/blogs/news/biotech-series-b-funding-scaling-innovation-to-commercial-success 2024-12-26T11:44:26+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_1.jpg?v=1735209791 Biotech Series B Funding: Scaling Innovation to Commercial Success https://bioxlist.com/blogs/news/biotech-series-c-funding-paving-the-way-to-market-leadership 2024-12-27T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-pixabay-529621.jpg?v=1735211548 Biotech Series C Funding: Paving the Way to Market Leadership https://bioxlist.com/blogs/news/biotech-series-d-funding-key-steps-to-secure-growth-capital 2024-12-30T11:39:43+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_2.jpg?v=1735555180 Biotech Series D Funding: Key Steps to Secure Growth Capital https://bioxlist.com/blogs/news/complete-guide-biotech-ipo-funding-process-amp-strategy 2024-12-31T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-pixabay-210607.jpg?v=1735577274 Complete Guide: Biotech IPO Funding Process & Strategy https://bioxlist.com/blogs/news/biotech-vc-career-guide-from-science-to-investment 2025-07-16T15:40:11+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_3_215de5f4-d1a6-4e38-b050-7710504ce7d0.jpg?v=1752673211 Biotech VC Career Guide: From Science to Investment https://bioxlist.com/blogs/news/biotech-boom-opportunities-and-risks-for-investors 2025-01-02T09:00:07+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_4.jpg?v=1735651863 Biotech Boom: Opportunities and Risks for Investors https://bioxlist.com/blogs/news/biotech-investment-stages-early-vs-late-funding-guide 2025-07-16T15:46:45+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_a8a08cbb-68ff-4f60-9727-352900c26ca4.jpg?v=1752673605 Biotech Investment Stages: Early vs. Late Funding Guide https://bioxlist.com/blogs/news/non-dilutive-funding-an-alternative-for-biotech-startups 2025-01-06T11:56:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-thinkscotty-298703.jpg?v=1736160927 Non-Dilutive Funding: An Alternative for Biotech Startups https://bioxlist.com/blogs/news/how-biotechs-can-attract-talent-in-a-competitive-market 2025-01-07T10:51:44+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_1_ce779b06-220e-48de-9942-f2b73c561b55.jpg?v=1736243382 How Biotechs Can Attract Talent in a Competitive Market https://bioxlist.com/blogs/news/strategic-guide-to-biotech-investment-opportunities 2025-01-08T10:59:39+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/dna-3539309_1280.jpg?v=1736330272 Strategic Guide to Biotech Investment Opportunities https://bioxlist.com/blogs/news/guide-to-investing-in-biotech-venture-capital 2025-01-09T10:57:09+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_2_2b242b4f-8d36-4b21-a2a2-58984571e103.jpg?v=1736416629 Guide to Investing in Biotech Venture Capital https://bioxlist.com/blogs/news/how-to-prepare-your-biotech-to-attract-investors 2025-01-10T13:19:05+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Webp.net-resizeimage_5_8e2167f8-1069-42e6-9583-4c095494ceda.jpg?v=1736511545 How to Prepare Your Biotech to Attract Investors https://bioxlist.com/blogs/news/venture-capital-vs-growth-capital-in-biotech-key-differences 2025-01-13T11:13:31+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-ben-cheung-140183-3038813.jpg?v=1736763211 Venture Capital vs. Growth Capital in Biotech: Key Differences https://bioxlist.com/blogs/news/decoding-biotech-vc-a-beginner-s-guide-to-joining-the-industry 2025-07-16T16:49:09+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-nickkwanhk-2693282_62ab034f-59bd-416c-8228-3f63d9b508a6.jpg?v=1752677349 Decoding Biotech VC: A Beginner’s Guide to Joining the Industry https://bioxlist.com/blogs/news/demystifying-biotech-valuations-what-every-vc-should-know 2025-01-15T10:34:30+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/toon-lambrechts-oO2lWdQfvms-unsplash_6b94fe42-0ff9-488b-ab74-96cc462aae0b.jpg?v=1736933670 Demystifying Biotech Valuations: What Every VC Should Know https://bioxlist.com/blogs/news/biotech-exit-strategies-ipo-vs-acquisition 2025-07-16T16:04:25+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/stock-exchange-4785080_1280_e322e963-997e-4132-a4b4-396f7cfec1e2.jpg?v=1752674665 Biotech Exit Strategies: IPO vs. Acquisition https://bioxlist.com/blogs/news/becoming-a-biotech-venture-capitalist-skills-strategies-and-insights 2025-01-17T11:09:53+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/BD_d84d5036-c7ae-42cf-aa2c-4a3436004e35.jpg?v=1737108593 Becoming a Biotech Venture Capitalist: Skills, Strategies, and Insights https://bioxlist.com/blogs/news/red-flags-in-biotech-investment-what-to-watch-for 2025-01-20T11:40:57+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/bio_8996922e-bee8-45bb-9dfd-c3063ac90878.webp?v=1737369657 Red Flags in Biotech Investment: What to Watch For https://bioxlist.com/blogs/news/international-biotech-funding-regional-differences-and-opportunities 2025-01-21T11:27:36+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/p_28cbc840-f1eb-4de6-b7a0-a62e507d814b.jpg?v=1737455256 International Biotech Funding: Regional Differences and Opportunities https://bioxlist.com/blogs/news/key-components-of-a-winning-biotech-pitch-deck 2025-01-22T10:08:11+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-rdne-7414284_f086ac61-1703-49fd-aee2-de74cc5cd50b.jpg?v=1737536891 Key Components of a Winning Biotech Pitch Deck https://bioxlist.com/blogs/news/key-metrics-for-evaluating-biotech-investment-opportunities 2025-07-16T16:01:44+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/p_1_8a5ca5fb-632f-4bd2-a73f-ce9e063505f5.jpg?v=1752674504 Key Metrics for Evaluating Biotech Investment Opportunities https://bioxlist.com/blogs/news/from-lab-to-launch-mastering-seed-funding-for-biotech-startups 2025-01-24T13:25:50+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/p_2_c98a79f3-d820-4732-a720-af5163ed6bad.jpg?v=1737721550 From Lab to Launch: Mastering Seed Funding for Biotech Startups https://bioxlist.com/blogs/news/biotech-venture-capital-where-science-meets-profit-and-why-it-matters 2025-01-27T10:07:40+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/print_703d0b13-28bb-4a47-a20e-f8d6547db929.jpg?v=1737968860 Biotech Venture Capital: Where Science Meets Profit (And Why It Matters) https://bioxlist.com/blogs/news/seed-funding-survival-guide-navigating-biotech-s-high-risk-high-reward-phase 2025-01-28T10:13:58+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/s_4e082b3b-6f23-47ed-ad8a-714ccadc5ac1.webp?v=1738055638 Seed Funding Survival Guide: Navigating Biotech’s High-Risk, High-Reward Phase https://bioxlist.com/blogs/news/biotech-vs-tech-startups-which-offers-better-returns-for-investors 2025-01-29T10:58:49+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Design_sans_titre_cf588a3a-10de-43c0-99eb-c8e6261eea62.png?v=1738144729 Biotech vs. Tech Startups: Which Offers Better Returns for Investors? https://bioxlist.com/blogs/news/how-to-build-a-biotech-stock-portfolio-key-steps-and-strategy-guide 2025-01-30T11:43:58+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/s_1_c290c737-8eb6-4db3-bb68-a92ceb80fa9d.webp?v=1738233838 How to Build a Biotech Stock Portfolio: Key Steps and Strategy Guide https://bioxlist.com/blogs/news/biotech-seed-funding-vs-tech-startups-why-the-rules-are-different 2025-01-31T14:16:12+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/Untitled_design_3_c5160a4d-7eec-4144-936d-e67cb32fa4d3.png?v=1738329372 Biotech Seed Funding vs. Tech Startups: Why the Rules Are Different https://bioxlist.com/blogs/news/beyond-the-lab-how-biotechs-can-prove-traction-before-seed-funding 2025-02-03T18:47:28+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/26.png?v=1738604848 Beyond the Lab: How Biotechs Can Prove Traction Before Seed Funding https://bioxlist.com/blogs/news/clinical-trial-success-rates-what-investors-need-to-know-before-betting-on-biotech-2 2025-02-04T13:17:40+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/8_b0fa3790-df5d-4e0e-9cd8-06f5ec78f6c2.png?v=1738671460 Clinical Trial Success Rates: What Investors Need to Know Before Betting on Biotech https://bioxlist.com/blogs/news/fda-fast-track-vs-breakthrough-therapy-which-one-attracts-more-vc-dollars 2025-02-05T11:49:45+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/37.png?v=1738752585 FDA Fast-Track vs. Breakthrough Therapy: Which One Attracts More VC Dollars? https://bioxlist.com/blogs/news/dilutive-or-non-dilutive-choosing-the-right-seed-funding-path-for-your-biotech 2025-02-06T11:42:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/165_e6119961-d351-4bdb-b347-ece5d9e2eed6.png?v=1738838521 Dilutive or Non-Dilutive? Choosing the Right Seed Funding Path for Your Biotech https://bioxlist.com/blogs/news/rdcf-the-key-to-valuing-high-risk-biotech-investments 2025-02-07T10:09:28+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/171_181bd229-d276-4de0-985c-7ba3974b32f1.png?v=1738919368 rDCF: The Key to Valuing High-Risk Biotech Investments https://bioxlist.com/blogs/news/pre-seed-vs-seed-timing-your-biotech-funding-for-maximum-impact 2025-07-16T15:47:07+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/162_0cfbb37b-2146-4a64-ae99-b262402d9049.png?v=1752673627 Pre-Seed vs. Seed: Timing Your Biotech Funding for Maximum Impact https://bioxlist.com/blogs/news/how-to-pitch-biotech-seed-investors-crafting-a-compelling-story 2025-02-17T09:10:13+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/57_3e7c4cea-77fb-4939-9dbf-4da43a77f6b7.png?v=1739779813 How to Pitch Biotech Seed Investors: Crafting a Compelling Story https://bioxlist.com/blogs/news/the-rise-of-corporate-venture-capital-in-biotech 2025-02-17T09:06:25+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/237_4d6a3325-27e7-494d-9d7f-b1b21473cce8.png?v=1739779585 The Rise of Corporate Venture Capital in Biotech https://bioxlist.com/blogs/news/building-a-robust-financial-model-for-your-biotech-startup 2025-07-16T15:56:28+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/178_2c420cce-e5b0-4167-9b0f-a3c8b500cd74.png?v=1752674188 Building a Robust Financial Model for Your Biotech Startup https://bioxlist.com/blogs/news/debt-financing-for-biotechs-when-venture-debt-makes-sense-and-when-it-doesn-t 2025-02-17T09:03:30+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/184_3d8fd65b-2c60-4098-a34f-f2490af0a70e.png?v=1739779410 Debt Financing for Biotechs: When Venture Debt Makes Sense (And When It Doesn’t) https://bioxlist.com/blogs/news/pre-money-vs-post-money-valuation-in-biotech-why-therapeutic-area-impacts-multipliers 2025-07-16T16:19:28+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/6_5107a272-cee4-40ac-95c8-6a042982b451.png?v=1752675568 Pre-Money vs. Post-Money Valuation in Biotech: Why Therapeutic Area Impacts Multipliers https://bioxlist.com/blogs/news/how-to-secure-international-biotech-vc-funding 2025-02-18T10:24:30+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/251_e24989d9-518d-4809-9023-ea0f4caa3724.png?v=1739870670 How to Secure International Biotech VC Funding https://bioxlist.com/blogs/news/biotech-board-seats-how-vcs-influence-startup-direction 2025-02-19T12:22:17+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/235_bc8db64f-a47f-4f9c-b847-aede657d9a72.png?v=1739964137 Biotech Board Seats: How VCs Influence Startup Direction https://bioxlist.com/blogs/news/transitioning-from-biotech-scientist-to-biotech-venture-capitalist 2025-07-16T16:35:13+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/253_644d2ea0-999d-4705-ba1f-7ef095f6769d.png?v=1752676513 Transitioning from Biotech Scientist to Biotech Venture Capitalist https://bioxlist.com/blogs/news/emerging-markets-in-biotech-investment-opportunities 2025-02-21T10:43:21+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/15_3417a656-8035-42a9-8b4f-994463557817.png?v=1740131001 Emerging Markets in Biotech: Investment Opportunities https://bioxlist.com/blogs/news/biotech-funding-what-is-a-venture-capital-1 2025-02-24T10:11:54+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/231_19f87e50-f458-4770-8e2e-1be016cbccdf.png?v=1740388314 Biotech Funding : What is a Venture Capital ? https://bioxlist.com/blogs/news/biotech-vc-networking-building-relationships-that-matter 2025-02-25T11:26:10+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/234_e17ac7cc-735a-4906-869d-ceaab2c7cca9.png?v=1740479170 Biotech VC Networking: Building Relationships That Matter https://bioxlist.com/blogs/news/balancing-risk-and-reward-in-biotech-investments 2025-02-26T10:57:59+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/193_9174030b-45c5-44ed-8b5d-bddc4388c116.png?v=1740563879 Balancing Risk and Reward in Biotech Investments https://bioxlist.com/blogs/news/digital-transformation-in-biotech-ai-big-data-and-investor-interest 2025-02-27T11:47:37+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/284_ab07996c-5f95-4be5-b263-bd80a45065eb.png?v=1740653257 Digital Transformation in Biotech: AI, Big Data, and Investor Interest https://bioxlist.com/blogs/news/7-critical-strategies-for-biotech-funding-success 2025-02-28T10:40:47+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/124_db845997-996d-4563-8f9e-ef661acebbd9.png?v=1740735647 Critical Strategies for Biotech Funding Success https://bioxlist.com/blogs/news/the-lp-perspective-how-biotech-venture-funds-raise-their-own-capital 2025-03-03T09:50:19+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/161_8be7f090-b4a5-405f-a6ed-01909cbc4fde.png?v=1740991819 The LP Perspective: How Biotech Venture Funds Raise Their Own Capital https://bioxlist.com/blogs/news/the-hidden-biotech-vc-criteria-what-founders-often-overlook 2025-03-04T10:30:45+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/28_af2f3fdb-3353-4a80-a518-c87943228050.png?v=1741080645 The Hidden Biotech VC Criteria: What Founders Often Overlook https://bioxlist.com/blogs/news/from-academia-to-biotech-vc-bridging-the-gap-for-scientists-turned-investors 2025-03-05T09:19:05+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/172_96dba6df-f3b0-4c9d-b439-3d0f5accc005.png?v=1741162745 From Academia to Biotech VC: Bridging the Gap for Scientists-Turned-Investors https://bioxlist.com/blogs/news/why-biotech-venture-capital-is-betting-on-ai-driven-drug-discovery 2025-03-06T10:33:21+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/71_2201898a-5990-4ddb-ae67-321b0e6f6cd4.png?v=1741253601 Why Biotech Venture Capital is Betting on AI-Driven Drug Discovery https://bioxlist.com/blogs/news/biotech-vc-partnerships-how-to-align-investor-and-founder-vision 2025-03-07T09:59:32+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/166_203e3c82-00fe-4e0c-b0be-6b01a9286d64.png?v=1741337972 Biotech VC Partnerships: How to Align Investor and Founder Vision https://bioxlist.com/blogs/news/how-biotech-vcs-evaluate-early-stage-startups-insider-secrets 2025-03-11T10:18:53+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/56_337e3f89-2c22-4a25-b1c1-d7db1c8f4867.png?v=1741684733 How Biotech VCs Evaluate Early-Stage Startups: Insider Secrets https://bioxlist.com/blogs/news/biotech-vc-due-diligence-a-founder-s-survival-checklist 2025-07-16T16:43:58+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/169_8ecb613a-8703-4d32-ad00-d081ed674113.png?v=1752677038 Biotech VC Due Diligence: A Founder’s Survival Checklist https://bioxlist.com/blogs/news/how-to-leverage-academic-research-for-biotech-vc-funding 2025-03-12T11:35:45+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/116_5b44912a-3803-4a5d-81bf-47dd5b780fe1.png?v=1741775745 How to Leverage Academic Research for Biotech VC Funding https://bioxlist.com/blogs/news/post-investment-playbook-managing-biotech-vc-relationships-long-term 2025-03-13T09:42:15+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/173_570cd1d9-5a18-4489-a077-30477102188e.png?v=1741855335 Post-Investment Playbook: Managing Biotech VC Relationships Long-Term https://bioxlist.com/blogs/news/behind-the-data-a-deep-dive-into-our-life-sciences-investor-list 2025-04-07T18:52:47+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/US2025_2_53b7aeac-4ec2-4ad6-896b-9014072508cb.png?v=1744044767 Your US Life Sciences Investor List: A Transparent Breakdown https://bioxlist.com/blogs/news/biotech-vc-exits-why-timing-matters-more-than-you-think 2025-03-14T10:12:23+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/197_436ec65b-a741-4359-a2d6-3773d0796040.png?v=1741943543 Biotech VC Exits: Why Timing Matters More Than You Think https://bioxlist.com/blogs/news/the-biotech-vc-talent-pipeline-how-to-break-in-without-a-finance-background 2025-03-17T09:28:25+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/236_58722225-331f-44bf-a6cc-a4a6eb274332.png?v=1742200105 The Biotech VC Talent Pipeline: How to Break In Without a Finance Background https://bioxlist.com/blogs/news/portfolio-math-why-biotech-vcs-bet-on-10-startups-to-get-1-unicorn 2025-03-18T10:59:42+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/177_0728bbd7-df7f-47d2-8914-772abddb1eab.png?v=1742291982 Portfolio Math: Why Biotech VCs Bet on 10 Startups to Get 1 Unicorn https://bioxlist.com/blogs/news/board-seats-101-what-biotech-venture-capitalists-really-want-from-governance 2025-03-19T17:04:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/228.png?v=1742400241 Board Seats 101: What Biotech Venture Capitalists Really Want From Governance https://bioxlist.com/blogs/news/seed-funding-secrets-how-biotech-startups-can-secure-early-stage-capital 2025-03-20T09:58:12+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/72.png?v=1742461092 Seed Funding Secrets: How Biotech Startups Can Secure Early-Stage Capital https://bioxlist.com/blogs/news/follow-on-funding-when-biotech-vcs-double-down-and-when-they-walk 2025-03-21T11:26:43+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/241_6d15fc91-26dd-4088-8ab9-a67337cea3a5.png?v=1742552803 Follow-On Funding: When Biotech VCs Double Down (And When They Walk) https://bioxlist.com/blogs/news/geography-matters-why-some-biotech-clusters-attract-the-majority-of-vc-dollars 2025-03-24T11:20:16+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/nasa-Q1p7bh3SHj8-unsplash_2_fca47612-6262-4203-8594-9e9d439509ab.webp?v=1742811616 Geography Matters: Why Some Biotech Clusters Attract the Majority of VC Dollars https://bioxlist.com/blogs/news/biotech-vc-syndication-why-your-startup-needs-competing-term-sheets 2025-03-25T11:12:43+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/154_3f477c62-0295-4066-9160-0f8b13f5a239.png?v=1742897563 Biotech VC Syndication: Why Your Startup Needs Competing Term Sheets https://bioxlist.com/blogs/news/clinical-trial-milestones-the-hidden-triggers-for-vc-follow-up-rounds 2025-03-26T10:30:14+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/54_aa82b914-09d8-4102-8b77-117ac6698c0b.png?v=1742981414 Clinical Trial Milestones: The Hidden Triggers for VC Follow-Up Rounds https://bioxlist.com/blogs/news/corporate-venture-capital-in-biotech-opportunities-and-challenges 2025-03-27T10:11:40+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/164_d6ceeae9-16c5-43c2-b749-43acfbfc7c42.png?v=1743066700 Corporate Venture Capital in Biotech: Opportunities and Challenges https://bioxlist.com/blogs/news/biotech-vs-medtech-why-vcs-treat-them-differently-hint-it-s-not-just-about-fda-pathways 2025-07-16T16:24:44+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/I_503166eb-f981-4e2d-bd38-d1426a711511.png?v=1752675884 Biotech vs. Medtech: Why VCs Treat Them Differently (Hint: It’s Not Just About FDA Pathways) https://bioxlist.com/blogs/news/post-investment-management-how-vcs-add-value-to-biotech-portfolio-companies 2025-03-31T09:40:56+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/254_6d7a6e5f-a39e-4ce1-bfaa-4a35ab055947.png?v=1743406856 Post-Investment Management: How VCs Add Value to Biotech Portfolio Companies https://bioxlist.com/blogs/news/the-hidden-costs-of-non-dilutive-funding-for-biotechs-when-grants-hurt-future-vc-rounds 2025-04-01T11:20:30+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/175_861756d6-dd5e-4a99-87cc-bf0a89cd2c04.png?v=1743499230 The Hidden Costs of Non-Dilutive Funding for Biotechs: When Grants Hurt Future VC Rounds https://bioxlist.com/blogs/news/top-mistakes-biotech-startups-make-when-pitching-to-investors 2025-04-02T11:32:28+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/158_20e9e47d-68b7-4263-9de6-6feeee76826b.png?v=1743586348 Top Mistakes Biotech Startups Make When Pitching to Investors https://bioxlist.com/blogs/news/how-to-build-a-strong-biotech-team-to-attract-vc-funding 2025-04-03T10:55:44+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/80.png?v=1743670544 How to Build a Strong Biotech Team to Attract VC Funding https://bioxlist.com/blogs/news/the-role-of-academia-in-biotech-investing-spinouts-you-can-t-afford-to-miss 2025-04-04T11:44:39+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/108_d703fc12-9a45-40cc-961a-881d1d2eb265.png?v=1743759879 The Role of Academia in Biotech Investing: Spinouts You Can’t Afford to Miss https://bioxlist.com/blogs/news/biotech-in-emerging-markets-high-risk-higher-reward 2025-04-07T10:54:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/245_ffc62517-e5f6-4e9c-9045-754668275f3e.png?v=1744016095 Biotech in Emerging Markets: High Risk, Higher Reward? https://bioxlist.com/blogs/news/your-us-therapeutics-investor-list-a-transparent-breakdown 2025-04-08T17:50:22+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/USTherapeutics2025_8e753c51-bf34-4882-8900-4978fb3fe1a8.png?v=1744127422 Your US Therapeutics Investor List: A Transparent Breakdown https://bioxlist.com/blogs/news/the-quiet-rise-of-biotech-secondary-markets-liquidity-before-ipo 2025-04-08T17:16:51+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/182_c7ce746f-5fe3-4b22-b88f-2b649c0d99d2.png?v=1744125411 The Quiet Rise of Biotech Secondary Markets: Liquidity Before IPO https://bioxlist.com/blogs/news/pre-money-vs-post-money-in-biotech-why-50m-series-a-doesn-t-mean-what-you-think 2025-04-09T11:48:47+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/64.png?v=1744192127 Pre-Money vs. Post-Money in Biotech: Why $50M Series A Doesn’t Mean What You Think https://bioxlist.com/blogs/news/the-secret-language-of-biotech-vc-term-sheets-key-clauses-decoded 2025-04-10T10:09:57+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/188_9c69ef2a-f548-4cc6-8b11-c424e36dae45.png?v=1744272597 The Secret Language of Biotech VC Term Sheets: Key Clauses Decoded https://bioxlist.com/blogs/news/top-6-biotech-venture-capital-firms-leading-early-2025-investments 2025-07-16T16:55:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/240_fcb3edaa-710b-4d78-9d5e-5df6cf43288a.png?v=1752677703 Top 6 Biotech Venture Capital Firms Leading Early 2025 Investments https://bioxlist.com/blogs/news/the-10x-rule-why-biotech-vcs-demand-10x-returns-and-how-dilution-erodes-it 2025-04-14T10:41:15+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/196_d36f70b1-8da4-427a-926d-018a6953e34c.png?v=1744620075 The 10x Rule: Why Biotech VCs Demand 10x Returns (and How Dilution Erodes It) https://bioxlist.com/blogs/news/platform-vs-asset-centric-models-why-vcs-bet-on-the-r-d-factory-over-single-molecules 2025-07-16T16:15:34+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/50_058a09cf-a909-4fbb-a284-04b840fc3b7a.png?v=1752675334 Platform vs. Asset-Centric Models: Why VCs Bet on the ‘R&D Factory’ Over Single Molecules https://bioxlist.com/blogs/news/biotech-etfs-vs-direct-equity-which-strategy-fits-your-risk-appetite 2025-04-16T11:14:53+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/191_d9da2e21-2811-438a-9807-28df10e6c056.png?v=1744794893 Biotech ETFs vs. Direct Equity: Which Strategy Fits Your Risk Appetite? https://bioxlist.com/blogs/news/the-silent-killer-in-biotech-vc-deals-how-dilution-creeps-post-series-b 2025-07-16T16:31:29+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/62_61a97a28-39b2-446b-becd-01453f7cfbf1.png?v=1752676289 The Silent Killer in Biotech VC Deals: How Dilution Creeps Post-Series B https://bioxlist.com/blogs/news/overfunded-or-undercapitalized-finding-the-sweet-spot-for-biotech-seed-rounds 2025-04-18T10:55:29+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/159.png?v=1744966529 Overfunded or Undercapitalized? Finding the Sweet Spot for Biotech Seed Rounds https://bioxlist.com/blogs/news/from-lab-leaks-to-ip-theft-insuring-biotech-s-uninsurable-risks 2025-04-21T10:14:36+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/77_b9daf1e9-bfd6-4584-94a3-af786dc95d4d.png?v=1745223276 From Lab Leaks to IP Theft: Insuring Biotech’s Uninsurable Risks https://bioxlist.com/blogs/news/from-failure-to-funding-pivoting-your-biotech-startup-for-vc-appeal 2025-04-22T09:30:15+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/130_d4024763-0c04-4d3b-b153-47ef1d210e2a.png?v=1745307015 From Failure to Funding: Pivoting Your Biotech Startup for VC Appeal https://bioxlist.com/blogs/news/how-biotech-vcs-calculate-risk-the-metrics-they-never-publicly-share 2025-07-16T16:53:50+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/178_16b68fb2-a95f-4500-8a9b-b62acb378a3e.png?v=1752677630 How Biotech VCs Calculate Risk: The Metrics They Never Publicly Share https://bioxlist.com/blogs/news/biotech-deal-flow-secrets-how-vcs-find-hidden-gem-startups-first 2025-04-24T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/155_7c346038-226f-45b2-bb09-46a2c3cf9f0d.png?v=1745332040 Biotech Deal Flow Secrets: How VCs Find Hidden-Gem Startups First https://bioxlist.com/blogs/news/the-regulatory-roadmap-how-biotech-vcs-pressure-test-fda-strategies 2025-04-25T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/150_b7d77306-45bb-49dc-8866-d28644ce6d0e.png?v=1745332369 The Regulatory Roadmap: How Biotech VCs Pressure-Test FDA Strategies https://bioxlist.com/blogs/news/biotech-s-black-box-valuing-pre-clinical-companies-without-revenue-or-data 2025-04-28T09:19:45+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/92_e23eaf8c-a39b-494e-a37a-a0cef6d45e66.png?v=1745824785 Biotech’s Black Box: Valuing Pre-Clinical Companies Without Revenue or Data https://bioxlist.com/blogs/news/biotech-funding-decoded-where-most-startups-find-their-first-1m-vc-grants-or-bootstrapping 2025-04-29T11:34:42+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/152_23276528-9c7d-45ca-855a-fb68304b72e0.png?v=1745919282 Biotech Funding Decoded: Where Most Startups Find Their First $1M (VC, Grants, or Bootstrapping?) https://bioxlist.com/blogs/news/from-handshake-to-close-the-unspoken-timeline-of-biotech-vc-investments 2025-04-30T08:59:54+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/180_f544d923-d597-4681-8ab5-d6e77b8cd1b0.png?v=1745996394 From Handshake to Close: The Unspoken Timeline of Biotech VC Investments https://bioxlist.com/blogs/news/step-by-step-how-to-get-an-internship-in-biotech-venture-capital 2025-07-16T16:00:46+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/239_48b79fb7-54a7-43f0-8feb-0c4db89f3d63.png?v=1752674446 Step-by-Step: How to Get an Internship in Biotech Venture Capital https://bioxlist.com/blogs/news/how-much-do-venture-capital-employees-make 2025-05-02T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/238_c1c148ae-70f6-43b0-9865-f83273dd53ef.png?v=1746084493 How Much Do Venture Capital Employees Make? https://bioxlist.com/blogs/news/the-role-of-carried-interest-in-biotech-venture-capital 2025-05-05T12:25:42+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/168.png?v=1746440742 The Role of Carried Interest in Biotech Venture Capital https://bioxlist.com/blogs/news/why-biotech-venture-capital-outperforms-traditional-sectors 2025-05-06T10:12:22+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/226_ae85fe0d-9f8b-4282-b93e-15bdd2c07cdf.png?v=1746519142 Why Biotech Venture Capital Outperforms Traditional Sectors ? https://bioxlist.com/blogs/news/alternative-funding-sources-for-biotech-grants-awards-and-foundations 2025-07-16T16:40:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/75_2cdd337e-efe3-425a-99c9-6970ee707ac1.png?v=1752676801 Alternative Funding Sources for Biotech: Grants, Awards, and Foundations https://bioxlist.com/blogs/news/agtech-funding-why-vcs-are-betting-big-on-the-future-of-agriculture 2025-05-08T11:07:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/78_dc9f85d7-dccf-41e2-b4ee-895e239cb779.png?v=1746695275 AgTech Funding: Why VCs Are Betting Big on the Future of Agriculture https://bioxlist.com/blogs/news/agtech-vs-biotech-why-the-funding-playbook-isn-t-the-same 2025-05-09T10:58:23+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/96_4636844e-ac7a-4d75-82d1-867dc5cf2e4a.png?v=1746781103 AgTech vs Biotech: Why the Funding Playbook Isn’t the Same https://bioxlist.com/blogs/news/pipeline-tetris-juggling-3-7-therapeutic-programs-in-a-single-startup-s-portfolio 2025-05-12T11:13:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/147_11a0a979-2d10-4e85-a83a-4cdac121e4eb.png?v=1747041235 Pipeline Tetris: Juggling 3-7 therapeutic programs in a single startup’s portfolio https://bioxlist.com/blogs/news/warrants-in-biotech-financing-a-tool-for-vcs-or-a-time-bomb-for-startups 2025-05-13T10:49:08+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-thirdman-5060979_1_4fe4f291-13c6-4dba-8326-d725fdd13f86.jpg?v=1747126148 Warrants in Biotech Financing: A Tool for VCs or a Time Bomb for Startups? https://bioxlist.com/blogs/news/down-rounds-in-biotech-how-to-navigate-when-phase-2-trials-fail 2025-05-14T21:13:05+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/270_41018476-d885-4b20-98f9-a84237c632d5.png?v=1747249985 Down Rounds in Biotech: How to Navigate When Phase 2 Trials Fail https://bioxlist.com/blogs/news/guide-to-biotech-licensing-deals-structuring-and-negotiation 2025-07-16T16:27:32+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/156_8ba9198b-171a-4da1-b2f3-374b2875b7cf.png?v=1752676052 Guide to Biotech Licensing Deals: Structuring and Negotiation https://bioxlist.com/blogs/news/what-is-a-biotech-venture-capital 2025-05-16T17:53:58+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/202.png?v=1747410838 What Is a Biotech Venture Capital? https://bioxlist.com/blogs/news/how-do-biotech-startups-get-funded 2025-05-19T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/283_89c49fbb-79d2-4fe5-b032-48bd2ab4db7b.png?v=1747411408 How Do Biotech Startups Get Funded? https://bioxlist.com/blogs/news/who-invests-in-biotech-and-why 2025-05-20T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/243_35d387d2-3157-4fd6-957d-cde8203ce3a8.png?v=1747411773 Who Invests in Biotech and Why? https://bioxlist.com/blogs/news/how-to-get-a-job-in-biotech-venture-capital 2025-05-21T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/153_ae314388-60e9-4ef8-afc7-e4785027e2da.png?v=1747412139 How to Get a Job in Biotech Venture Capital https://bioxlist.com/blogs/news/how-to-pitch-your-biotech-startup-to-vcs 2025-05-22T09:30:08+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/167_9f1f8a9d-d632-4c41-a912-51fd23e2ccb5.png?v=1747412444 How to Pitch Your Biotech Startup to VCs https://bioxlist.com/blogs/news/how-biotech-startups-can-attract-venture-capital 2025-05-23T09:30:08+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/136_0874c5f3-851f-48fa-b71f-6d5349b62a80.png?v=1747413538 How Biotech Startups Can Attract Venture Capital https://bioxlist.com/blogs/news/from-seed-to-series-b-stages-of-biotech-funding 2025-05-26T19:32:44+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/65_588e80fa-e3d3-42ee-afc5-761c4a8fcc4b.png?v=1748280764 From Seed to Series B: Stages of Biotech Funding https://bioxlist.com/blogs/news/the-role-of-venture-capital-in-biotech-startups 2025-05-27T11:30:32+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/225_cdcd4fd1-fe45-4818-a531-b4453191cbdf.png?v=1748338232 The Role of Venture Capital in Biotech Startups https://bioxlist.com/blogs/news/what-does-a-career-in-biotech-vc-look-like 2025-05-28T09:39:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/224.png?v=1748417995 What Does a Career in Biotech VC Look Like? https://bioxlist.com/blogs/news/inside-a-biotech-vc-firm-how-investment-decisions-are-made 2025-05-29T08:46:39+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/242.png?v=1748501199 Inside a Biotech VC Firm: How Investment Decisions Are Made https://bioxlist.com/blogs/news/how-to-start-investing-in-biotech-ventures 2025-05-30T10:59:46+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/204.png?v=1748595586 How to Start Investing in Biotech Ventures https://bioxlist.com/blogs/news/equity-dilution-risk-biotech-funding-basics-for-founders 2025-06-02T10:42:24+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/55.png?v=1748853744 Equity, Dilution & Risk: Biotech Funding Basics for Founders https://bioxlist.com/blogs/news/essential-skills-for-success-in-biotech-venture-capital-vc 2025-06-03T09:58:49+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/163.png?v=1748937529 Essential Skills for Success in Biotech Venture Capital (VC) https://bioxlist.com/blogs/news/common-mistakes-biotech-founders-make-when-fundraising 2025-06-04T11:47:43+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/73_69668a2b-ec08-4a9c-900e-e6746a314f66.png?v=1749030463 Common Mistakes Biotech Founders Make When Fundraising https://bioxlist.com/blogs/news/from-phd-to-vc-transitioning-to-biotech-investment 2025-06-05T09:12:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/21_51769d7e-f244-4d04-86f5-0dc6d9b59da1.png?v=1749107522 From PhD to VC: Transitioning to Biotech Investment https://bioxlist.com/blogs/news/the-role-of-ipos-and-m-a-in-biotech-vc-exits 2025-06-06T10:22:40+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/186.png?v=1749198160 The Role of IPOs and M&A in Biotech VC Exits https://bioxlist.com/blogs/news/do-you-need-a-science-background-to-work-in-biotech-vc 2025-06-09T09:40:48+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/219_deeb0fb2-20a4-4aaf-a351-278480859246.png?v=1749454848 Do You Need a Science Background to Work in Biotech VC? https://bioxlist.com/blogs/news/the-perfect-biotech-pitch-deck-what-investors-expect 2025-06-10T09:04:17+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/224_57ce5d90-129d-419b-b7bc-3b125bdc7b8d.png?v=1749539057 The Perfect Biotech Pitch Deck: What Investors Expect https://bioxlist.com/blogs/news/the-due-diligue-process-in-biotech-investing 2025-06-11T10:08:13+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/157.png?v=1749629293 The Due Diligue Process in Biotech Investing https://bioxlist.com/blogs/news/day-in-the-life-of-a-biotech-venture-capitalist 2025-06-12T09:00:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/227_baf064c6-989b-4641-b1cc-cd65b9663b43.png?v=1749629922 Day in the Life of a Biotech Venture Capitalist https://bioxlist.com/blogs/news/networking-tips-for-aspiring-biotech-vc-professionals 2025-06-13T09:00:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/179.png?v=1749630981 Networking Tips for Aspiring Biotech VC Professionals https://bioxlist.com/blogs/news/why-biotech-ventures-are-high-risk-high-reward-investments 2025-06-16T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/30.png?v=1750027096 Why Biotech Ventures Are High-Risk, High-Reward Investments https://bioxlist.com/blogs/news/how-to-navigate-clinical-trial-risks-as-a-biotech-investor 2025-06-17T08:24:59+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/60.png?v=1750141499 How to Navigate Clinical Trial Risks as a Biotech Investor https://bioxlist.com/blogs/news/how-much-should-you-raise-for-your-biotech-startup 2025-06-18T10:34:47+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/134.png?v=1750235687 How Much Should You Raise for Your Biotech Startup? https://bioxlist.com/blogs/news/how-do-biotech-vcs-raise-their-own-funds 2025-06-19T15:21:45+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/255.png?v=1750339305 How Do Biotech VCs Raise Their Own Funds? https://bioxlist.com/blogs/news/why-biotech-startups-need-so-much-capital 2025-06-20T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/90.png?v=1750339660 Why Biotech Startups Need So Much Capital https://bioxlist.com/blogs/news/how-biotech-vcs-evaluate-startups 2025-06-23T10:00:56+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/160.png?v=1750665656 How Biotech VCs Evaluate Startups https://bioxlist.com/blogs/news/therapeutic-areas-that-attract-the-most-vc-money 2025-06-24T10:45:15+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/87_d94bee01-b24e-473b-beee-8cd6754022fb.png?v=1750754715 Therapeutic Areas That Attract the Most VC Money https://bioxlist.com/blogs/news/how-to-build-a-cap-table-for-a-biotech-company 2025-06-25T12:18:14+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/138.png?v=1750846694 How to Build a Cap Table for a Biotech Company https://bioxlist.com/blogs/news/common-mistakes-biotech-entrepreneurs-make-when-pitching-to-vcs 2025-06-26T16:16:41+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/174_550291ca-918d-4f78-b6f0-da161c3aeaaf.png?v=1750947401 Common Mistakes Biotech Entrepreneurs Make When Pitching to VCs https://bioxlist.com/blogs/news/public-vs-private-funding-in-biotech-what-you-need-to-know 2025-06-27T10:59:34+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/126.png?v=1751014774 Public vs. Private Funding in Biotech: What You Need to Know https://bioxlist.com/blogs/news/the-role-of-scientific-advisors-in-biotech-vc 2025-06-30T10:19:37+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/88_37cf2be1-969b-4441-8796-0cbd02b756d2.png?v=1751271577 The Role of Scientific Advisors in Biotech VC https://bioxlist.com/blogs/news/how-to-impress-a-biotech-vc-as-an-analyst-candidate 2025-07-01T11:09:12+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/286.png?v=1751360952 How to Impress a Biotech VC as an Analyst Candidate https://bioxlist.com/blogs/news/how-biotech-venture-capitalists-drive-innovation-in-healthcare 2025-07-02T11:06:00+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/181.png?v=1751447160 How Biotech Venture Capitalists Drive Innovation in Healthcare https://bioxlist.com/blogs/news/the-biotech-funding-landscape-an-introduction 2025-07-03T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/246_0d043e31-1b1f-4aed-8e45-e1514103501f.png?v=1751448554 The Biotech Funding Landscape: An Introduction https://bioxlist.com/blogs/news/top-5-metrics-biotech-venture-capitalists-use-to-evaluate-startups 2025-07-04T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/183.png?v=1751449029 Top 5 Metrics Biotech Venture Capitalists Use to Evaluate Startups https://bioxlist.com/blogs/news/from-hype-to-reality-how-biotech-vcs-navigate-scientific-risk 2025-07-07T11:25:53+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/36.png?v=1751880353 From Hype to Reality: How Biotech VCs Navigate Scientific Risk https://bioxlist.com/blogs/news/beyond-venture-capital-alternative-funding-options-for-biotechs 2025-07-08T10:01:58+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/214_63798c7e-95e1-457d-82ef-b599892404f9.png?v=1751961718 Beyond Venture Capital: Alternative Funding Options for Biotechs https://bioxlist.com/blogs/news/biotech-venture-capital-glossary-key-terms 2025-07-09T10:23:27+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/95.png?v=1752049407 Biotech Venture Capital Glossary: Key Terms https://bioxlist.com/blogs/news/how-biotech-investors-build-a-diversified-portfolio 2025-07-10T12:41:52+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/250_2e9a6b33-d6f3-477f-94a9-188887697382.png?v=1752144112 How Biotech Investors Build a Diversified Portfolio https://bioxlist.com/blogs/news/regulatory-shifts-impacting-biotech-investments 2025-07-11T09:37:19+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-polina-tankilevitch-6927356_c3e76857-cea7-45e0-b13b-aa6e6ce22c33.jpg?v=1752219439 Regulatory Shifts Impacting Biotech Investments https://bioxlist.com/blogs/news/seed-vs-series-a-funding-stages-in-biotech 2025-07-14T21:12:08+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/115.png?v=1752520328 Seed vs. Series A: Funding Stages in Biotech https://bioxlist.com/blogs/news/emerging-markets-in-biotech-where-vcs-are-betting-now 2025-07-15T12:38:38+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/248.png?v=1752575918 Emerging Markets in Biotech: Where VCs Are Betting Now https://bioxlist.com/blogs/news/how-to-raise-venture-capital-for-an-agritech-startup 2025-07-16T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/139.png?v=1752613672 How to Raise Venture Capital for an AgriTech Startup https://bioxlist.com/blogs/news/how-to-write-a-standout-cover-letter-for-a-biotech-vc-internship 2025-07-17T09:30:07+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/glenn-carstens-peters-npxXWgQ33ZQ-unsplash_2e05f5b8-c685-4027-8354-97b6050bd51a.jpg?v=1752675149 How to Write a Standout Cover Letter for a Biotech VC Internship https://bioxlist.com/blogs/news/the-role-of-ai-in-next-gen-diagnostic-startups 2025-07-18T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/85.png?v=1752614754 The Role of AI in Next-Gen Diagnostic Startups https://bioxlist.com/blogs/news/preferred-vs-common-shares-what-biotech-founders-need-to-know 2025-07-21T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/249.png?v=1752615676 Preferred vs Common Shares: What Biotech Founders Need to Know https://bioxlist.com/blogs/news/what-investors-look-for-in-foodtech-startups 2025-07-22T00:00:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/eaters-collective-i_xVfNtQjwI-unsplash.jpg?v=1752616106 What Investors Look for in FoodTech Startups https://bioxlist.com/blogs/news/what-investors-look-for-in-early-stage-digital-health-companies 2025-07-23T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/luke-chesser-rCOWMC8qf8A-unsplash.jpg?v=1752616452 What Investors Look for in Early-Stage Digital Health Companies https://bioxlist.com/blogs/news/how-liquidation-preferences-impact-biotech-founders 2025-07-24T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/195.png?v=1752616709 How Liquidation Preferences Impact Biotech Founders https://bioxlist.com/blogs/news/essential-financial-modeling-skills-for-biotech-vc-interns 2025-07-25T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/198.png?v=1752616956 Essential Financial Modeling Skills for Biotech VC Interns https://bioxlist.com/blogs/news/inside-a-medtech-vc-pitch-what-investors-want-to-hear 2025-07-28T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/290.png?v=1752617247 Inside a MedTech VC Pitch: What Investors Want to Hear https://bioxlist.com/blogs/news/how-to-position-your-medtech-startup-in-a-crowded-market 2025-07-29T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/292_a8191985-e5e1-4cab-ab16-68d170af4d34.png?v=1752617672 How to Position Your MedTech Startup in a Crowded Market https://bioxlist.com/blogs/news/building-a-fundraising-strategy-for-a-medtech-company 2025-07-30T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/291.png?v=1752618014 Building a Fundraising Strategy for a MedTech Company https://bioxlist.com/blogs/news/how-investors-evaluate-risk-in-medtech-startups 2025-07-31T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/294.png?v=1752618290 How Investors Evaluate Risk in MedTech Startups https://bioxlist.com/blogs/news/how-to-raise-venture-capital-for-your-medtech-startup 2025-08-01T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/293.png?v=1752618710 How to Raise Venture Capital for Your MedTech Startup https://bioxlist.com/blogs/news/how-biotech-startups-secure-venture-capital-investment 2025-08-04T12:32:28+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/271.png?v=1754303548 How Biotech Startups Secure Venture Capital Investment https://bioxlist.com/blogs/news/key-criteria-biotech-venture-capitalists-use-to-evaluate-your-startup 2025-08-05T11:10:59+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/79.png?v=1754385059 Key Criteria Biotech Venture Capitalists Use to Evaluate Your Startup https://bioxlist.com/blogs/news/biotech-venture-capital-explained-from-seed-to-series-a 2025-08-06T10:18:36+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/14.png?v=1754468316 Biotech Venture Capital Explained: From Seed to Series A https://bioxlist.com/blogs/news/how-preferred-shares-impact-founders-and-investors-in-biotech 2025-08-07T09:18:49+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/252_e9076b44-373f-46fe-b600-fe8a0f1518e2.png?v=1754551129 Preferred Shares in Biotech: Who Wins? https://bioxlist.com/blogs/news/what-are-liquidation-preferences-in-venture-capital 2025-08-08T09:16:53+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/sean-pollock-PhYq704ffdA-unsplash.jpg?v=1754637413 What Are Liquidation Preferences in Venture Capital? https://bioxlist.com/blogs/news/how-cap-tables-work-a-biotech-founder-s-guide-to-ownership 2025-08-11T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/towfiqu-barbhuiya-nApaSgkzaxg-unsplash.jpg?v=1754671469 How Cap Tables Work: A Biotech Founder’s Guide to Ownership https://bioxlist.com/blogs/news/what-are-pro-rata-rights-in-venture-capital 2025-08-12T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/jeffrey-blum-7-gaPkhIgqs-unsplash.jpg?v=1754671679 What Are Pro Rata Rights in Venture Capital? https://bioxlist.com/blogs/news/how-to-raise-venture-capital-for-a-therapeutics-company 2025-08-13T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/102.png?v=1754671887 How to Raise Venture Capital for a Therapeutics Company https://bioxlist.com/blogs/news/inside-biotech-venture-capital-a-day-in-the-life-of-an-intern 2025-08-14T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/jason-goodman-Oalh2MojUuk-unsplash.jpg?v=1754672181 Inside Biotech Venture Capital: A Day in the Life of an Intern https://bioxlist.com/blogs/news/biotech-venture-capital-investment-process-from-pitch-deck-to-funding 2025-08-15T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/samson-ZGjbiukp_-A-unsplash_90b89ee3-2d70-4c5c-a756-5214eeb94cb2.jpg?v=1754673020 Biotech Venture Capital Investment Process: From Pitch Deck to Funding https://bioxlist.com/blogs/news/the-hidden-cost-of-venture-capital-why-liquidation-preferences-matter 2025-08-18T09:16:44+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-essow-k-251295-936722.jpg?v=1755501404 The Hidden Cost of Venture Capital: Why Liquidation Preferences Matter https://bioxlist.com/blogs/news/founder-vesting-in-biotech-startups-best-practices 2025-08-19T09:19:07+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/andreas-brucker-C2Dyr5FhGPQ-unsplash.jpg?v=1755587947 Founder Vesting in Biotech Startups: Best Practices https://bioxlist.com/blogs/news/the-future-of-medtech-funding-where-the-money-goes 2025-08-20T08:51:33+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/300.png?v=1755672693 The Future of MedTech Funding: Where the Money Goes https://bioxlist.com/blogs/news/top-100-biotech-venture-capital-vc-firms 2026-01-06T21:58:21+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/B_8ada96bd-cfe5-4808-a1dc-822bfa4c1e4a.jpg?v=1767733101 Top 100 Biotech Venture Capital (VC) Firms Upward view of a corporate building, a biotech venture capital firm buidling https://bioxlist.com/blogs/news/the-lifecycle-of-a-biotech-venture-capital-investment 2025-08-21T09:53:37+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/23_bc49bba0-0850-4d11-95ab-549f7fd07347.png?v=1755762817 The Lifecycle of a Biotech Venture Capital Investment https://bioxlist.com/blogs/news/clinical-trials-in-medtech-what-vcs-expect-before-funding 2025-08-25T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/303_34a131e3-f4c7-4363-a204-81c32b5cfd3d.png?v=1755877822 Clinical Trials in MedTech: What VCs Expect Before Funding Surgical robot in an operating room, illustrating MedTech innovation for clinical trials and VC funding expectations https://bioxlist.com/blogs/news/how-to-raise-venture-capital-for-a-diagnostics-company 2025-08-26T09:30:05+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/272_c713b5e4-7c61-44a1-843c-abef1b7f6d1e.png?v=1755877974 How to Raise Venture Capital for a Diagnostics Company PCR test tubes in a diagnostics lab with a pipette dispensing liquid, illustrating venture capital fundraising needs for Diagnostics startups https://bioxlist.com/blogs/news/what-makes-an-agritech-startup-attractive-to-investors 2025-08-27T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/143_36bbac8c-11bd-49a7-ad60-0c526bc7634f.png?v=1755878089 What Makes an AgriTech Startup Attractive to Investors? Woman using a tablet in a greenhouse with plants, representing AgriTech innovation that attracts investors https://bioxlist.com/blogs/news/pitching-a-digital-health-startup-key-metrics-that-matter-to-vcs 2025-08-28T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/national-cancer-institute-cQ8FfVNvbew-unsplash_b1aea8d4-d758-4ba3-931d-b2de98c78197.jpg?v=1755878191 Pitching a Digital Health Startup: Key Metrics That Matter to VCs Female doctor in a white coat with a stethoscope holding a smartphone, symbolizing digital health startups pitching key metrics to VCs https://bioxlist.com/blogs/news/top-mistakes-digital-health-founders-make-when-raising-capital 2025-08-29T18:00:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/luke-chesser-rCOWMC8qf8A-unsplash_5a329bad-3700-4e4d-9216-2bb288a789c6.jpg?v=1755878347 Top Mistakes Digital Health Founders Make When Raising Capital Smartwatch on a person’s wrist displaying health data, symbolizing digital health technology in fundraising context https://bioxlist.com/blogs/news/cap-table-mistakes-that-kill-biotech-fundraising-rounds 2025-09-01T08:23:07+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/209_c21392fb-1477-4aa8-880f-d1aa05fbd7a7.png?v=1756707787 Cap Table Mistakes That Kill Biotech Fundraising Rounds https://bioxlist.com/blogs/news/everything-you-need-to-know-about-biotech-vc-term-sheets 2025-09-02T10:05:00+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/306.png?v=1756800300 Everything You Need to Know About Biotech VC Term Sheets https://bioxlist.com/blogs/news/biotech-startup-founders-beware-of-these-liquidation-clauses 2025-09-03T10:07:57+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/307_85502c82-fabc-417c-ae51-5c812b09e868.png?v=1756886877 Biotech Startup Founders: Beware of These Liquidation Clauses https://bioxlist.com/blogs/news/biotech-vc-funding-key-steps-for-first-time-founders 2025-09-04T14:51:28+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/308_d4eceb10-2bc4-4be2-881b-7330f7c7d799.png?v=1756990288 Biotech VC Funding: Key Steps for First-Time Founders https://bioxlist.com/blogs/news/what-investors-look-for-in-diagnostics-startups 2025-09-05T10:13:56+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/268.png?v=1757060036 What Investors Look for in Diagnostics Startups https://bioxlist.com/blogs/news/inside-the-agritech-pitch-what-vcs-want-to-hear 2025-09-08T11:10:08+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/149_44ee1e0d-8f65-45f9-a8da-b5f2008165e4.png?v=1757322608 Inside the AgriTech Pitch: What VCs Want to Hear https://bioxlist.com/blogs/news/from-fda-approval-to-fundraising-a-medtech-startup-s-journey 2025-09-09T09:41:14+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/299.png?v=1757403674 From FDA Approval to Fundraising: A MedTech Startup’s Journey https://bioxlist.com/blogs/news/mastering-your-biotech-vc-pitch-what-investors-really-want 2025-09-10T13:19:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/pexels-goumbik-590016.jpg?v=1757503195 Mastering Your Biotech VC Pitch: What Investors Really Want https://bioxlist.com/blogs/news/how-biotech-venture-capitalists-structure-their-deals 2025-09-11T09:47:38+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/305.png?v=1757576858 How Biotech Venture Capitalists Structure Their Deals https://bioxlist.com/blogs/news/how-to-build-a-fundable-pipeline-in-therapeutics 2025-09-12T09:40:21+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/16_47b262ae-b25b-48bd-81e1-fb7ae3cb58de.png?v=1757662821 How to Build a Fundable Pipeline in Therapeutics Automated laboratory system with rows of vials for therapeutics research https://bioxlist.com/blogs/news/how-to-de-risk-a-therapeutics-startup-for-vc-investors 2025-09-15T09:41:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/98_0874b7a0-e73d-4190-89e6-e5f1ae32a71a.png?v=1757922061 How to De-Risk a Therapeutics Startup for VC Investors https://bioxlist.com/blogs/news/how-investor-exit-rights-can-affect-your-biotech-deal 2025-09-16T15:05:54+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/55_d51af8cc-716d-4c41-9aa2-df3705f93a26.png?v=1758027954 How Investor Exit Rights Can Affect Your Biotech Deal https://bioxlist.com/blogs/news/why-participation-rights-can-eat-into-your-biotech-exit 2025-09-17T09:25:15+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/131_2_5047ab35-d7ca-4f9e-a434-ca91e9a2763f.png?v=1758093915 Why Participation Rights Can Eat into Your Biotech Exit https://bioxlist.com/blogs/news/top-50-medtech-venture-capital-vc-firms 2026-01-06T22:04:49+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/295_e4605a0e-1e8e-482c-8c4f-73ea16e3e3dd.png?v=1767733489 Top 50 MedTech Venture Capital (VC) Firms A surgical robot with four arms on a blue background. https://bioxlist.com/blogs/news/essential-metrics-every-biotech-founder-should-track-for-venture-capital 2025-09-19T08:35:20+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/155_21c8c88b-fef7-4b6f-80d6-3b9b5fc52811.png?v=1758263720 Essential Metrics Every Biotech Founder Should Track for Venture Capital https://bioxlist.com/blogs/news/how-agtech-founders-can-build-investor-ready-business-models 2025-09-22T09:14:38+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/184_637d5797-4cdb-489d-bc88-f31ce1f34b90.png?v=1758525278 How AgTech Founders Can Build Investor-Ready Business Models https://bioxlist.com/blogs/news/the-rise-of-precision-agriculture-and-its-investment-potential 2025-09-23T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/188_5f78ba03-806e-4c26-b4a0-c34e2c1d4a1c.png?v=1758525766 The Rise of Precision Agriculture and Its Investment Potential https://bioxlist.com/blogs/news/biotech-vc-strategies-how-investors-pick-winners 2025-09-24T12:14:14+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/61_2_1b52fc9d-473a-42a7-8d19-eabec3b174f4.png?v=1758708854 Biotech VC Strategies: How Investors Pick Winners https://bioxlist.com/blogs/news/how-to-negotiate-a-valuation-in-biotech-6-tactics-that-work 2025-09-25T10:23:48+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/36_610dfc77-1962-404e-b6a1-7612376d3376.png?v=1758788628 How to Negotiate a Valuation in Biotech: 6 Tactics That Work https://bioxlist.com/blogs/news/how-to-vet-a-vc-before-accepting-an-investment 2025-09-26T11:13:15+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/4_2.png?v=1758877995 How to Vet a VC Before Accepting an Investment https://bioxlist.com/blogs/news/how-to-become-an-analyst-in-biotech-vc-a-complete-roadmap 2025-09-29T09:47:51+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/30_d59de129-777e-484e-9d17-78229f78582a.png?v=1759132071 How to Become an Analyst in Biotech VC: A Complete Roadmap https://bioxlist.com/blogs/news/convertible-notes-vs-safes-what-s-best-for-biotech-startups 2025-09-30T14:56:37+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/6_00ce0bb5-96a5-4c02-9efb-b882d2420c55.png?v=1759236997 Convertible Notes vs SAFEs: What’s Best for Biotech Startups? https://bioxlist.com/blogs/news/why-biotech-venture-capital-is-critical-for-scientific-breakthroughs 2025-10-01T11:43:44+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/104_2_61af2a1a-9c79-46ed-80d0-c9da775ebd13.png?v=1759311824 Why Biotech Venture Capital Is Critical for Scientific Breakthroughs https://bioxlist.com/blogs/news/what-biotech-vcs-see-in-60-seconds-of-a-pitch-deck 2025-10-02T10:12:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/16_2.png?v=1759392775 What Biotech VCs See in 60 Seconds of a Pitch Deck https://bioxlist.com/blogs/news/how-to-avoid-hidden-dilution-in-biotech-after-a-series-b 2025-10-03T10:45:55+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/93_2.png?v=1759481154 How to Avoid Hidden Dilution in Biotech After a Series B https://bioxlist.com/blogs/news/setting-up-a-delaware-c-corp-a-practical-guide-for-biotech-founders 2025-10-06T14:14:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/chris-henry-UM9kOT9kyBI-unsplash.jpg?v=1759752844 Setting Up a Delaware C-Corp: A Practical Guide for Biotech Founders Bridge in Delaware at dusk https://bioxlist.com/blogs/news/how-to-structure-initial-shareholders-in-your-us-biotech-startup 2025-10-07T12:16:47+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/17_2.png?v=1759832207 How to Structure Initial Shareholders in Your US Biotech Startup Two people sitting at a table with a laptop and papers showing charts and graphs. https://bioxlist.com/blogs/news/cap-table-from-day-one-for-biotech-founders-fundamentals-and-common-pitfalls 2025-10-08T10:55:17+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/10_2_041482d4-9594-4a0f-9f26-071591cd0784.png?v=1759913717 Cap Table from Day One for Biotech Founders: Fundamentals and Common Pitfalls A person sitting at a desk using a laptop and calculator, reviewing financial documents and making calculations. https://bioxlist.com/blogs/news/delaware-c-corp-vs-llc-for-early-stage-biotech-what-to-choose 2025-10-09T09:37:21+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/102_90375446-0767-43f4-a62f-7979254958ff.png?v=1759995441 Delaware C-Corp vs LLC for Early Stage Biotech: What to Choose https://bioxlist.com/blogs/news/founders-equity-splits-in-biotech-fair-approaches-and-legal-steps 2025-10-10T11:44:37+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/8_bfb30ab2-9543-49b2-acdb-5606e8435805.png?v=1760089477 Founders Equity Splits in Biotech: Fair Approaches and Legal Steps https://bioxlist.com/blogs/news/stock-vesting-and-83b-elections-what-biotech-founders-must-know 2025-10-13T10:37:48+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/73_ba13b7e2-991e-4bca-8eba-d2af420ac907.png?v=1760344668 Stock Vesting and 83(b) Elections: What Biotech Founders Must Know https://bioxlist.com/blogs/news/how-to-create-an-investor-friendly-biotech-cap-table-without-losing-control 2025-10-14T10:50:09+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/5_2.png?v=1760431809 How to Create an Investor-Friendly Biotech Cap Table Without Losing Control https://bioxlist.com/blogs/news/basic-us-tax-implications-for-early-stage-biotech-founders 2025-10-15T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/46_2.png?v=1760434444 Basic US Tax Implications for Early Stage Biotech Founders https://bioxlist.com/blogs/news/preparing-your-biotech-cap-table-for-fundraising 2025-10-16T10:43:38+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/11_52e7e173-26ed-4fe2-8c0b-4e2c980a0fbf.png?v=1760604218 Preparing Your Biotech Cap Table for Fundraising https://bioxlist.com/blogs/news/how-to-document-initial-equity-issuances-in-biotech-and-avoid-future-headaches 2025-10-17T10:11:50+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/31_2.png?v=1760688710 How to Document Initial Equity Issuances in Biotech and Avoid Future Headaches https://bioxlist.com/blogs/news/employee-stock-options-and-option-pool-basics-for-biotech-startups 2025-10-20T13:04:43+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/199.png?v=1760958283 Employee Stock Options and Option Pool Basics for Biotech Startups https://bioxlist.com/blogs/news/when-to-incorporate-in-delaware-for-a-biotech-startup-timing-and-practical-steps 2025-10-21T09:30:08+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/75_6298912c-6091-4aed-a65f-f110779f60ce.png?v=1760958520 When to Incorporate in Delaware for a Biotech Startup: Timing and Practical Steps https://bioxlist.com/blogs/news/common-term-sheet-clauses-that-affect-your-biotech-cap-table 2025-10-22T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/13_2_8105ff24-666f-4fa9-959e-33b3cd93da42.png?v=1760958794 Common Term Sheet Clauses That Affect Your Biotech Cap Table https://bioxlist.com/blogs/news/avoiding-hidden-dilution-in-biotech-practical-cap-table-simulations 2025-10-23T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/52_2.png?v=1760958997 Avoiding Hidden Dilution in Biotech: Practical Cap Table Simulations https://bioxlist.com/blogs/news/how-to-run-a-409a-valuation-for-biotech-startups-and-why-it-matters 2025-10-24T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/45_2.png?v=1760959451 How to Run a 409A Valuation for Biotech Startups and Why It Matters https://bioxlist.com/blogs/news/founder-separation-and-equity-buyback-in-biotech-legal-protections-to-put-in-place 2025-10-27T11:25:42+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/38_2.png?v=1761560742 Founder Separation and Equity Buyback in Biotech: Legal Protections to Put in Place https://bioxlist.com/blogs/news/early-biotech-cap-table-clean-up-what-investors-will-check 2025-10-28T09:25:59+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/12_2.png?v=1761639959 Early Biotech Cap Table Clean Up: What Investors Will Check https://bioxlist.com/blogs/news/equity-grants-for-biotech-advisors-and-consultants-rules-and-best-practices 2025-10-29T10:54:16+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/51_2.png?v=1761731656 Equity Grants for Biotech Advisors and Consultants: Rules and Best Practices https://bioxlist.com/blogs/news/tax-efficient-equity-compensation-strategies-for-biotech-founders-and-early-hires 2025-10-30T10:53:31+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/1_d32b9d39-03fa-414f-bb40-b6767614a449.png?v=1761818011 Tax Efficient Equity Compensation Strategies for Biotech Founders and Early Hires https://bioxlist.com/blogs/news/biotech-cap-table-governance-tools-processes-and-who-owns-what 2025-10-31T11:11:14+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/20_2_cd75cb4a-b546-4417-ab94-cdfefd2c4d3a.png?v=1761905474 Biotech Cap Table Governance: Tools, Processes and Who Owns What https://bioxlist.com/blogs/news/biotech-founders-agreement-essentials-roles-responsibilities-and-decision-rights 2025-11-03T12:31:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/35_2_8367a628-aca3-4477-b118-32cc280390fb.png?v=1762169461 Biotech Founders Agreement Essentials: Roles, Responsibilities and Decision Rights https://bioxlist.com/blogs/news/how-to-structure-a-biotech-founder-vesting-schedule-four-years-and-one-year-cliff-explained 2025-11-04T10:35:29+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/24_2.png?v=1762248929 How to Structure a Biotech Founder Vesting Schedule: Four Years and One Year Cliff Explained https://bioxlist.com/blogs/news/biotech-founder-governance-setting-power-balance-without-slowing-decisions 2025-11-05T09:30:07+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/15_2_acc3a26c-dddd-4c42-9feb-4d1e225586ce.png?v=1762249558 Biotech Founder Governance: Setting Power Balance Without Slowing Decisions https://bioxlist.com/blogs/news/biotech-founder-breakup-clauses-how-to-protect-the-company-if-someone-leaves 2025-11-06T11:03:16+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/39_2_b7da22df-e012-4f9b-85f4-bca341d110e3.png?v=1762423396 Biotech Founder Breakup Clauses: How to Protect the Company if Someone Leaves https://bioxlist.com/blogs/news/splitting-responsibilities-in-a-biotech-startup-scientific-vs-business-leadership 2025-11-07T14:09:28+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/41_2.png?v=1762520968 Splitting Responsibilities in a Biotech Startup: Scientific vs Business Leadership https://bioxlist.com/blogs/news/biotech-founder-decision-rights-what-requires-joint-approval-vs-ceo-autonomy 2025-11-10T11:26:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/68.png?v=1762770360 Biotech Founder Decision Rights: What Requires Joint Approval vs CEO Autonomy https://bioxlist.com/blogs/news/vesting-for-biotech-founders-how-to-avoid-future-equity-disputes 2025-11-11T10:45:05+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/7_2.png?v=1762854305 Vesting for Biotech Founders: How to Avoid Future Equity Disputes https://bioxlist.com/blogs/news/biotech-founder-departure-scenarios-good-leaver-vs-bad-leaver-terms 2025-11-12T09:01:27+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/25_2_b423f788-d4b2-4250-8bc1-bb7eb9aa966b.png?v=1762934487 Biotech Founder Departure Scenarios: Good Leaver vs Bad Leaver Terms https://bioxlist.com/blogs/news/governance-for-biotech-teams-boards-advisors-and-founder-voting-rules 2025-11-13T10:53:33+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/130_1421e85b-f137-4a1d-8283-844213acd392.png?v=1763027613 Governance for Biotech Teams: Boards, Advisors and Founder Voting Rules https://bioxlist.com/blogs/news/biotech-founder-legal-protections-clauses-that-prevent-internal-conflicts 2025-11-14T14:03:45+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/135_2.png?v=1763125425 Biotech Founder Legal Protections: Clauses That Prevent Internal Conflicts https://bioxlist.com/blogs/news/biotech-founders-agreements-key-clauses-every-early-team-should-include 2025-11-17T12:52:23+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/70_2.png?v=1763380343 Biotech Founders Agreements: Key Clauses Every Early Team Should Include https://bioxlist.com/blogs/news/biotech-founder-vesting-schedules-explained-the-4-year-1-year-cliff-model 2025-11-18T12:29:24+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/10_2_1f7e593e-9e19-4695-8ba3-113a75ab32df.png?v=1763465364 Biotech Founder Vesting Schedules Explained: The 4-Year / 1-Year Cliff Model https://bioxlist.com/blogs/news/avoiding-co-founder-conflicts-in-biotech-legal-and-practical-safeguards 2025-11-19T11:36:14+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/171_d5abab4b-df4f-40c7-a8aa-61d2b5a0fd95.png?v=1763548574 Avoiding Co-Founder Conflicts in Biotech: Legal and Practical Safeguards https://bioxlist.com/blogs/news/how-to-structure-decision-making-authority-in-an-early-biotech-company 2025-11-20T12:53:21+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/74_2_6341ea87-76bd-4dda-aa50-c36831eaea04.png?v=1763639601 How to Structure Decision-Making Authority in an Early Biotech Company https://bioxlist.com/blogs/news/how-to-choose-the-right-business-bank-account-for-your-biotech-startup 2025-11-21T10:20:43+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/107_2.png?v=1763716843 How to Choose the Right Business Bank Account for Your Biotech Startup https://bioxlist.com/blogs/news/multi-currency-accounts-for-biotech-startups-when-do-you-need-one 2025-11-24T10:25:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/69_2.png?v=1763976302 Multi-Currency Accounts for Biotech Startups: When Do You Need One? https://bioxlist.com/blogs/news/invoice-management-systems-for-early-stage-biotech-companies 2025-11-25T11:05:33+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/2_2.png?v=1764065133 Invoice Management Systems for Early-Stage Biotech Companies https://bioxlist.com/blogs/news/setting-up-your-biotech-billing-process-from-quote-to-payment 2025-11-26T13:18:55+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/22_2.png?v=1764159535 Setting Up Your Biotech Billing Process: From Quote to Payment https://bioxlist.com/blogs/news/payment-terms-and-collections-for-biotech-service-providers 2025-11-27T09:53:20+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/9_99ad2a35-54b5-429b-be8e-68e957023b91.png?v=1764233600 Payment Terms and Collections for Biotech Service Providers https://bioxlist.com/blogs/news/payroll-setup-guide-for-biotech-founders-hiring-their-first-employees 2025-11-28T11:27:04+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/27_2.png?v=1764325624 Payroll Setup Guide for Biotech Founders Hiring Their First Employees https://bioxlist.com/blogs/news/contractor-vs-employee-classification-in-biotech-financial-implications 2025-12-01T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/27_84265273-508b-47f2-9749-024a943ef8a3.png?v=1764326294 Contractor vs Employee Classification in Biotech: Financial Implications https://bioxlist.com/blogs/news/equity-compensation-and-payroll-what-biotech-founders-need-to-know 2025-12-02T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/22_2_167a9c5f-aa01-4fe8-9c29-536b2e54dd15.png?v=1764326504 Equity Compensation and Payroll: What Biotech Founders Need to Know https://bioxlist.com/blogs/news/essential-accounting-software-for-pre-revenue-biotech-startups 2025-12-03T09:48:05+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/14_49f96644-e415-464d-9510-40f20c0226d7.png?v=1764751685 Essential Accounting Software for Pre-Revenue Biotech Startups https://bioxlist.com/blogs/news/chart-of-accounts-setup-for-biotech-companies-a-practical-guide 2025-12-04T09:50:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/48_2.png?v=1764838200 Chart of Accounts Setup for Biotech Companies: A Practical Guide https://bioxlist.com/blogs/news/cash-flow-management-fundamentals-for-biotech-startups 2025-12-05T12:09:35+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/18_2_70225143-d70d-4ef6-a452-e34a4da252ed.png?v=1764932975 Cash Flow Management Fundamentals for Biotech Startups https://bioxlist.com/blogs/news/separating-personal-and-business-finances-in-early-stage-biotech 2025-12-08T09:15:16+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/44_2.png?v=1765181716 Separating Personal and Business Finances in Early-Stage Biotech https://bioxlist.com/blogs/news/building-financial-processes-that-scale-with-your-biotech-company 2025-12-09T10:34:42+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/96_5b0248ec-7826-4884-8b96-9a29403e4846.png?v=1765272882 Building Financial Processes That Scale with Your Biotech Company https://bioxlist.com/blogs/news/biotech-cap-table-fundamentals-building-your-master-file-before-series-a 2025-12-10T12:42:58+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/3_2_bab99910-bc79-452a-a403-4d649ec34871.png?v=1765366978 Biotech Cap Table Fundamentals: Building Your Master File Before Series A https://bioxlist.com/blogs/news/dilution-modeling-for-biotech-founders-how-to-project-ownership-through-multiple-rounds 2025-12-11T11:38:46+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/39.png?v=1765449526 Dilution Modeling for Biotech Founders: How to Project Ownership Through Multiple Rounds https://bioxlist.com/blogs/news/option-pool-strategy-in-biotech-sizing-and-timing-to-minimize-founder-dilution 2025-12-12T10:14:30+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/32_2_d92669ec-8d86-4157-a00e-e60cdea866c8.png?v=1765530870 Option Pool Strategy in Biotech: Sizing and Timing to Minimize Founder Dilution https://bioxlist.com/blogs/news/warrant-structures-in-biotech-financing-tracking-and-dilution-impact-analysis 2025-12-15T11:31:26+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/50_7933c283-15a0-4cfc-adea-9ad381270d59.png?v=1765794686 Warrant Structures in Biotech Financing: Tracking and Dilution Impact Analysis https://bioxlist.com/blogs/news/pre-money-vs-post-money-valuations-what-biotech-founders-need-to-calculate-dilution-correctly 2025-12-16T11:34:27+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/103_2.png?v=1765881267 Pre-Money vs Post-Money Valuations: What Biotech Founders Need to Calculate Dilution Correctly https://bioxlist.com/blogs/news/anti-dilution-provisions-in-biotech-term-sheets-weighted-average-vs-full-ratchet-protection 2025-12-17T11:46:45+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/117_2.png?v=1765968405 Anti-Dilution Provisions in Biotech Term Sheets: Weighted Average vs Full Ratchet Protection https://bioxlist.com/blogs/news/biotech-employee-equity-esop-management-and-vesting-schedule-integration-in-your-cap-table 2025-12-18T11:20:52+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/40_2.png?v=1766053252 Biotech Employee Equity: ESOP Management and Vesting Schedule Integration in Your Cap Table https://bioxlist.com/blogs/news/bridge-rounds-and-convertible-notes-in-biotech-modeling-future-dilution-from-safes-and-debt-conversion 2025-12-19T11:45:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/80_8ea04072-4f82-4441-9d11-5f28c5b8e246.png?v=1766141102 Bridge Rounds and Convertible Notes in Biotech: Modeling Future Dilution from SAFEs and Debt Conversion https://bioxlist.com/blogs/news/secondary-transaction-management-for-biotech-startups-updating-your-cap-table-without-triggering-rights 2025-12-22T14:50:24+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/88_4856bfd9-1f9b-445e-b42c-703fc45b6954.png?v=1766411424 Secondary Transaction Management for Biotech Startups: Updating Your Cap Table Without Triggering Rights https://bioxlist.com/blogs/news/biotech-co-founder-equity-splits-vesting-structures-and-dilution-proof-agreements 2025-12-23T12:31:57+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/132_2_b7256077-eee3-4c4b-a2b6-50c90002e6a4.png?v=1766489517 Biotech Co-Founder Equity Splits: Vesting Structures and Dilution-Proof Agreements https://bioxlist.com/blogs/news/pro-rata-rights-and-participation-rights-how-investor-protections-affect-biotech-founder-dilution 2025-12-24T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/114_2_b422ea6b-d84f-46a9-b52c-0814f4ca5070.png?v=1766490039 Pro Rata Rights and Participation Rights: How Investor Protections Affect Biotech Founder Dilution https://bioxlist.com/blogs/news/409a-valuations-for-biotech-companies-impact-on-option-grants-and-cap-table-planning 2025-12-25T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/120_2_41e2211f-15a8-4232-b9c2-e85a1071edcd.png?v=1766490770 409A Valuations for Biotech Companies: Impact on Option Grants and Cap Table Planning https://bioxlist.com/blogs/news/the-83b-election-for-biotech-founders-why-you-have-30-days-to-save-thousands-in-taxes 2025-12-26T09:30:04+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/113_2_e23f8f56-6c0d-49f6-94a0-3da5a7e488c9.png?v=1766491275 The 83(b) Election for Biotech Founders: Why You Have 30 Days to Save Thousands in Taxes https://bioxlist.com/blogs/news/vesting-schedules-in-biotech-startups-standard-4-year-structures-and-when-to-deviate 2025-12-29T09:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/97_2_a03758ed-5931-4875-a9ff-6e7659cb2aa7.png?v=1766491564 Vesting Schedules in Biotech Startups: Standard 4-Year Structures and When to Deviate https://bioxlist.com/blogs/news/cliff-periods-for-biotech-founders-negotiating-one-year-cliffs-in-co-founder-agreements 2025-12-30T09:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/134_b23746de-c42a-442c-8e56-269f11fb7089.png?v=1766492193 Cliff Periods for Biotech Founders: Negotiating One-Year Cliffs in Co-Founder Agreements https://bioxlist.com/blogs/news/83b-election-filing-process-for-biotech-equity-step-by-step-irs-submission-and-proof-of-delivery 2025-12-31T09:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/85_8545a8c7-deaa-4ab9-826a-9a922a238446.png?v=1766492382 83(b) Election Filing Process for Biotech Equity: Step-by-Step IRS Submission and Proof of Delivery https://bioxlist.com/blogs/news/acceleration-clauses-in-biotech-vesting-single-vs-double-trigger-on-acquisition 2026-01-01T09:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/60_d722d77d-6dc8-4941-94be-45992a4e74de.png?v=1766492528 Acceleration Clauses in Biotech Vesting: Single vs Double Trigger on Acquisition https://bioxlist.com/blogs/news/restricted-stock-vs-stock-options-in-biotech-how-vesting-and-83b-apply-differently 2026-01-02T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/90_a4d2910f-d20d-4f01-9fc9-a1468495af77.png?v=1766492804 Restricted Stock vs Stock Options in Biotech: How Vesting and 83(b) Apply Differently https://bioxlist.com/blogs/news/early-exercise-provisions-for-biotech-employees-enabling-83b-elections-before-vesting 2026-01-05T14:00:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/111_2_51cbf738-aef0-4e37-96ca-a856559edb82.png?v=1766493524 Early Exercise Provisions for Biotech Employees: Enabling 83(b) Elections Before Vesting https://bioxlist.com/blogs/news/reverse-vesting-for-biotech-co-founders-protecting-company-equity-from-early-departures 2026-01-06T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/142_2_09ee2ebf-3e35-492e-bc37-a64af16d56f4.png?v=1766497363 Reverse Vesting for Biotech Co-Founders: Protecting Company Equity from Early Departures https://bioxlist.com/blogs/news/tax-implications-of-skipping-the-83b-election-in-biotech-ordinary-income-vs-capital-gains 2026-01-07T21:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/70_2_dc5e8119-64ae-4622-83ff-5df1441ff09c.png?v=1766497595 Tax Implications of Skipping the 83(b) Election in Biotech: Ordinary Income vs Capital Gains https://bioxlist.com/blogs/news/vesting-acceleration-negotiation-for-biotech-founders-what-to-request-in-term-sheets 2026-01-08T09:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/96_64ba784d-1d7c-4ceb-a5f3-4c9f0e76a47f.png?v=1766497765 Vesting Acceleration Negotiation for Biotech Founders: What to Request in Term Sheets https://bioxlist.com/blogs/news/unvested-equity-forfeiture-in-biotech-what-happens-when-founders-or-employees-leave-early 2026-01-09T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/126_9ee7d8a8-e24a-4a76-8ba5-0c1ff149628b.png?v=1766497919 Unvested Equity Forfeiture in Biotech: What Happens When Founders or Employees Leave Early https://bioxlist.com/blogs/news/83b-elections-after-funding-rounds-how-biotech-valuation-changes-affect-your-tax-strategy 2026-01-12T15:00:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/165_d84ca314-cefe-437c-ae4c-0be03ae69c5e.png?v=1766498062 83(b) Elections After Funding Rounds: How Biotech Valuation Changes Affect Your Tax Strategy https://bioxlist.com/blogs/news/option-pool-sizing-for-biotech-startups-calculating-the-right-percentage-for-your-hiring-plan 2026-01-13T15:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/152_4b304c0d-8ef2-467c-905e-48bb300107ff.png?v=1766498619 Option Pool Sizing for Biotech Startups: Calculating the Right Percentage for Your Hiring Plan https://bioxlist.com/blogs/news/pre-money-vs-post-money-option-pools-in-biotech-who-bears-the-dilution-cost 2026-01-14T21:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/145_2.png?v=1766498774 Pre-Money vs Post-Money Option Pools in Biotech: Who Bears the Dilution Cost https://bioxlist.com/blogs/news/the-dilutive-impact-of-option-pools-on-biotech-founders-quantifying-immediate-ownership-loss 2026-01-15T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/151_2_64b62b61-573b-4339-8e41-f54b335b3d4f.png?v=1766498991 The Dilutive Impact of Option Pools on Biotech Founders: Quantifying Immediate Ownership Loss https://bioxlist.com/blogs/news/negotiating-option-pool-size-with-biotech-investors-defending-against-oversized-demands 2026-01-16T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/124_13b71511-c461-44de-b53a-e61613ee338f.png?v=1766499385 Negotiating Option Pool Size with Biotech Investors: Defending Against Oversized Demands https://bioxlist.com/blogs/news/option-pool-refresh-strategy-for-biotech-companies-when-and-how-to-expand-your-esop 2026-01-19T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/110_2.png?v=1767891228 Option Pool Refresh Strategy for Biotech Companies: When and How to Expand Your ESOP https://bioxlist.com/blogs/news/biotech-hiring-projections-and-option-pool-planning-aligning-equity-reserves-with-18-month-roadmaps 2026-01-20T21:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/106.png?v=1767902684 Biotech Hiring Projections and Option Pool Planning: Aligning Equity Reserves with 18-Month Roadmaps https://bioxlist.com/blogs/news/option-pool-creation-timing-in-biotech-before-series-a-vs-after-first-hires 2026-01-21T21:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/91_2.png?v=1767902892 Option Pool Creation Timing in Biotech: Before Series A vs After First Hires https://bioxlist.com/blogs/news/fully-diluted-ownership-in-biotech-how-unallocated-option-pool-shares-affect-founder-percentages 2026-01-22T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/119_2.png?v=1767903015 Fully Diluted Ownership in Biotech: How Unallocated Option Pool Shares Affect Founder Percentages https://bioxlist.com/blogs/news/biotech-investor-requirements-for-option-pools-standard-expectations-from-vcs-and-strategic-investors 2026-01-23T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/53_2.png?v=1767903396 Biotech Investor Requirements for Option Pools: Standard Expectations from VCs and Strategic Investors https://bioxlist.com/blogs/news/option-pool-carve-outs-in-biotech-term-sheets-reading-the-fine-print-on-esop-provisions 2026-01-26T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/149_77f6d562-ae3c-4b58-a09a-d8875e20079a.png?v=1767903589 Option Pool Carve-Outs in Biotech Term Sheets: Reading the Fine Print on ESOP Provisions https://bioxlist.com/blogs/news/dynamic-option-pool-management-for-biotech-adjusting-reserves-as-valuation-and-team-needs-evolve 2026-01-27T09:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/108_78f75bf2-8b0e-4f69-ab57-0f8df6a49423.png?v=1767903795 Dynamic Option Pool Management for Biotech: Adjusting Reserves as Valuation and Team Needs Evolve https://bioxlist.com/blogs/news/option-pool-accounting-in-biotech-cap-tables-allocated-vs-unallocated-shares-and-reporting 2026-01-28T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/305_60515c83-dadb-4790-a19a-b02a69a6d3dc.png?v=1767904506 Option Pool Accounting in Biotech Cap Tables: Allocated vs Unallocated Shares and Reporting https://bioxlist.com/blogs/news/biotech-term-sheet-fundamentals-understanding-valuation-amount-and-key-economic-terms 2026-01-29T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/142.png?v=1767905588 Biotech Term Sheet Fundamentals: Understanding Valuation, Amount, and Key Economic Terms https://bioxlist.com/blogs/news/liquidation-preferences-in-biotech-deals-why-1x-non-participating-is-standard-and-what-to-avoid 2026-01-30T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/162_9196807b-0066-41f9-9ef5-fa4824dc7bce.png?v=1767905864 Liquidation Preferences in Biotech Deals: Why 1x Non-Participating is Standard and What to Avoid https://bioxlist.com/blogs/news/participating-vs-non-participating-liquidation-in-biotech-calculating-founder-payout-scenarios 2026-02-02T09:30:00+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/83_2_adfadba5-bcd1-4d33-9e4a-ca516797b2e9.png?v=1768251027 Participating vs Non-Participating Liquidation in Biotech: Calculating Founder Payout Scenarios https://bioxlist.com/blogs/news/weighted-average-anti-dilution-protection-in-biotech-narrow-based-vs-broad-based-formulas 2026-02-03T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/82_2_3569bd71-bd4e-43f4-a3c1-d803bfbe8e0f.png?v=1768251196 Weighted Average Anti-Dilution Protection in Biotech: Narrow-Based vs Broad-Based Formulas https://bioxlist.com/blogs/news/protective-provisions-in-biotech-term-sheets-which-veto-rights-vcs-request-and-why 2026-02-04T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/78_84565649-0d22-4f8c-9840-fa7d473589ef.png?v=1768251463 Protective Provisions in Biotech Term Sheets: Which Veto Rights VCs Request and Why https://bioxlist.com/blogs/news/pre-money-valuation-negotiation-for-biotech-founders-benchmarking-against-development-stage 2026-02-05T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/99_2_8181aa8a-e41c-4ee6-8323-7eff598ba4bd.png?v=1768251719 Pre-Money Valuation Negotiation for Biotech Founders: Benchmarking Against Development Stage https://bioxlist.com/blogs/news/multiple-liquidation-preferences-in-biotech-when-investors-request-2x-or-3x-and-how-to-push-back 2026-02-06T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/122_2_0ae21689-8dff-4500-8c60-5eb7767e540f.png?v=1768251976 Multiple Liquidation Preferences in Biotech: When Investors Request 2x or 3x and How to Push Back https://bioxlist.com/blogs/news/full-ratchet-anti-dilution-in-biotech-understanding-the-harshest-protection-and-avoiding-it 2026-02-09T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/121_2_e432cb0b-59d7-43eb-9d7e-68ea81910d94.png?v=1768252232 Full Ratchet Anti-Dilution in Biotech: Understanding the Harshest Protection and Avoiding It https://bioxlist.com/blogs/news/board-composition-clauses-in-biotech-term-sheets-balancing-control-between-founders-and-investors 2026-02-10T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/123_2_bea68687-999c-4d46-85e6-f7b647e2e59b.png?v=1768252390 Board Composition Clauses in Biotech Term Sheets: Balancing Control Between Founders and Investors https://bioxlist.com/blogs/news/pay-to-play-provisions-in-biotech-financing-how-they-protect-against-non-participating-investors 2026-02-11T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/112_2_25be9aeb-670c-4ea4-a7d5-d7556d5d2290.png?v=1768252550 Pay-to-Play Provisions in Biotech Financing: How They Protect Against Non-Participating Investors https://bioxlist.com/blogs/news/redemption-rights-in-biotech-term-sheets-when-investors-can-force-company-buybacks 2026-02-12T15:00:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/63_2_a48e1bac-0112-47a9-b2dc-67d291eb0c68.png?v=1768398400 Redemption Rights in Biotech Term Sheets: When Investors Can Force Company Buybacks https://bioxlist.com/blogs/news/conversion-rights-and-mechanics-in-biotech-preferred-stock-automatic-vs-optional-triggers 2026-02-13T15:00:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/43_2_fb04b2c1-e566-48a5-a13b-e2cc430c781f.png?v=1768398587 Conversion Rights and Mechanics in Biotech Preferred Stock: Automatic vs Optional Triggers https://bioxlist.com/blogs/news/biotech-term-sheet-negotiation-framework-building-your-no-go-list-before-investor-meetings 2026-02-16T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/42_2_c430f1cd-0c7b-4953-82a7-9f9c58bdbe5c.png?v=1768399888 Biotech Term Sheet Negotiation Framework: Building Your No-Go List Before Investor Meetings https://bioxlist.com/blogs/news/tradeable-terms-in-biotech-financing-which-clauses-to-compromise-and-which-to-defend 2026-02-17T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/57_6e6033bd-3e91-4b3c-aa5f-b96ec6433e42.png?v=1768400087 Tradeable Terms in Biotech Financing: Which Clauses to Compromise and Which to Defend https://bioxlist.com/blogs/news/batna-development-for-biotech-founders-strengthening-your-negotiation-position-with-alternatives 2026-02-18T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/161_45424479-279b-4947-92d5-0128818bf406.png?v=1768400261 BATNA Development for Biotech Founders: Strengthening Your Negotiation Position with Alternatives https://bioxlist.com/blogs/news/requesting-comparable-deals-in-biotech-how-to-ask-vcs-for-past-term-sheet-examples 2026-02-19T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/133_2.png?v=1768400627 Requesting Comparable Deals in Biotech: How to Ask VCs for Past Term Sheet Examples https://bioxlist.com/blogs/news/red-lines-in-biotech-term-sheets-identifying-deal-breakers-before-you-start-negotiating 2026-02-20T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/166_c116b754-b356-438b-8a50-46d7fe5d6ddb.png?v=1768400834 Red Lines in Biotech Term Sheets: Identifying Deal-Breakers Before You Start Negotiating https://bioxlist.com/blogs/news/prioritizing-negotiation-points-in-biotech-economic-terms-vs-control-terms-vs-governance 2026-02-23T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/89_2.png?v=1768401182 Prioritizing Negotiation Points in Biotech: Economic Terms vs Control Terms vs Governance https://bioxlist.com/blogs/news/biotech-founder-leverage-assessment-when-you-can-push-back-and-when-to-accept-standard-terms 2026-02-24T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/87_07771aae-ffb3-47e3-8a09-43626527c537.png?v=1768401346 Biotech Founder Leverage Assessment: When You Can Push Back and When to Accept Standard Terms https://bioxlist.com/blogs/news/term-sheet-markup-strategy-for-biotech-how-to-propose-counteroffers-without-killing-the-deal 2026-02-25T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/92_94994e11-499e-48c8-b916-9b27d5848408.png?v=1768401522 Term Sheet Markup Strategy for Biotech: How to Propose Counteroffers Without Killing the Deal https://bioxlist.com/blogs/news/due-diligence-on-biotech-investors-researching-their-deal-history-and-reputation-before-signing 2026-02-26T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/58_2_64e2f92e-1017-46e7-afdc-92a902b75957.png?v=1768401718 Due Diligence on Biotech Investors: Researching Their Deal History and Reputation Before Signing https://bioxlist.com/blogs/news/multi-term-sheet-scenarios-in-biotech-using-competing-offers-to-improve-your-terms 2026-02-27T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/64_ae68cbfe-ecdf-4a05-9be1-ba5b9b676fa5.png?v=1768401881 Multi-Term Sheet Scenarios in Biotech: Using Competing Offers to Improve Your Terms https://bioxlist.com/blogs/news/legal-counsel-coordination-for-biotech-term-sheets-maximizing-your-attorneys-negotiation-value 2026-03-02T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/49_2.png?v=1768402352 Legal Counsel Coordination for Biotech Term Sheets: Maximizing Your Attorney's Negotiation Value https://bioxlist.com/blogs/news/timeline-management-in-biotech-term-sheet-negotiations-balancing-speed-with-thoroughness 2026-03-03T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/76_2_1fd0cc75-5221-4585-a593-633d3a6017e1.png?v=1768402477 Timeline Management in Biotech Term Sheet Negotiations: Balancing Speed with Thoroughness https://bioxlist.com/blogs/news/ip-assignment-agreements-for-biotech-founders-securing-ownership-before-day-one 2026-03-04T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/72_3a1ec713-b683-460c-8544-90aaa10ffa9c.png?v=1768428605 IP Assignment Agreements for Biotech Founders: Securing Ownership Before Day One https://bioxlist.com/blogs/news/biotech-employee-ip-assignment-essential-contract-clauses-to-include-in-offer-letters 2026-03-05T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/148_2_ea02e18c-ff38-454f-b9e0-ef6ab15d5dbd.png?v=1768428829 Biotech Employee IP Assignment: Essential Contract Clauses to Include in Offer Letters https://bioxlist.com/blogs/news/contractor-and-consultant-ip-rights-in-biotech-ensuring-work-for-hire-provisions-are-ironclad 2026-03-06T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/156_d1d90ea7-b578-4284-82db-c9ad54c120f5.png?v=1768429081 Contractor and Consultant IP Rights in Biotech: Ensuring Work-for-Hire Provisions Are Ironclad https://bioxlist.com/blogs/news/retroactive-ip-assignment-risks-in-biotech-why-pre-work-signatures-are-non-negotiable 2026-03-10T23:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/86_2.png?v=1768429310 Retroactive IP Assignment Risks in Biotech: Why Pre-Work Signatures Are Non-Negotiable https://bioxlist.com/blogs/news/co-founder-ip-assignment-in-biotech-startups-documenting-contributions-before-incorporation 2026-03-10T10:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/139_91a97ff1-a641-443d-97c0-640b8a703515.png?v=1768429630 Co-Founder IP Assignment in Biotech Startups: Documenting Contributions Before Incorporation https://bioxlist.com/blogs/news/academic-collaborator-ip-assignment-for-biotech-navigating-university-ownership-claims 2026-03-11T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/93.png?v=1768429817 Academic Collaborator IP Assignment for Biotech: Navigating University Ownership Claims https://bioxlist.com/blogs/news/biotech-advisor-ip-agreements-protecting-your-company-from-equity-for-ip-complications 2026-03-12T09:30:05+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/34_c34c892f-1c55-42f8-a19e-5254ca082a5a.png?v=1768430032 Biotech Advisor IP Agreements: Protecting Your Company from Equity-for-IP Complications https://bioxlist.com/blogs/news/pre-incorporation-ip-assignment-in-biotech-transferring-founder-inventions-to-the-new-entity 2026-03-13T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/67_2_dc2ef602-beeb-4a8e-9431-276d3c7387ec.png?v=1768430208 Pre-Incorporation IP Assignment in Biotech: Transferring Founder Inventions to the New Entity https://bioxlist.com/blogs/news/international-contractor-ip-assignment-for-biotech-jurisdiction-specific-requirements-and-pitfalls 2026-03-16T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/137_2.png?v=1768430462 International Contractor IP Assignment for Biotech: Jurisdiction-Specific Requirements and Pitfalls https://bioxlist.com/blogs/news/patent-inventorship-vs-ownership-in-biotech-why-assignment-agreements-override-default-rules 2026-03-17T21:30:04+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/136_b4fc5aea-a4b7-40bf-a731-329b7d32be9d.png?v=1768430703 Patent Inventorship vs Ownership in Biotech: Why Assignment Agreements Override Default Rules https://bioxlist.com/blogs/news/biotech-ip-assignment-audit-checklist-verifying-complete-chain-of-title-before-fundraising 2026-03-18T09:30:07+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/169_5e49689b-22c7-4b4b-8e9e-1171fd00a6fc.png?v=1768430971 Biotech IP Assignment Audit Checklist: Verifying Complete Chain of Title Before Fundraising https://bioxlist.com/blogs/news/background-ip-and-prior-inventions-in-biotech-carving-out-personal-work-from-company-assignment 2026-03-19T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/61.png?v=1768431230 Background IP and Prior Inventions in Biotech: Carving Out Personal Work from Company Assignment https://bioxlist.com/blogs/news/provisional-patent-applications-in-biotech-when-to-file-before-full-patent-prosecution 2026-03-20T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/89.png?v=1768431425 Provisional Patent Applications in Biotech: When to File Before Full Patent Prosecution https://bioxlist.com/blogs/news/lab-notebook-best-practices-for-biotech-startups-creating-admissible-evidence-of-invention 2026-03-23T09:30:02+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/37_d11735b1-971c-47a9-8b0e-d84cb067480e.png?v=1768485194 Lab Notebook Best Practices for Biotech Startups: Creating Admissible Evidence of Invention https://bioxlist.com/blogs/news/inventorship-documentation-in-biotech-building-a-defensible-record-of-who-invented-what 2026-03-24T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/29_2.png?v=1768485488 Inventorship Documentation in Biotech: Building a Defensible Record of Who Invented What https://bioxlist.com/blogs/news/electronic-lab-notebooks-for-biotech-ip-protection-digital-systems-that-satisfy-legal-requirements 2026-03-26T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/13_1dbd6956-5643-4926-9224-e2621be32073.png?v=1768663985 Electronic Lab Notebooks for Biotech IP Protection: Digital Systems That Satisfy Legal Requirements https://bioxlist.com/blogs/news/witnessed-and-dated-records-in-biotech-corroborating-invention-dates-for-patent-priority 2026-03-25T09:30:03+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/17_3f40ddab-d606-44ef-824d-eacc5f35677c.png?v=1768663741 Witnessed and Dated Records in Biotech: Corroborating Invention Dates for Patent Priority https://bioxlist.com/blogs/news/biotech-invention-disclosure-process-internal-workflows-to-capture-ip-before-its-lost 2026-03-27T09:30:01+01:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/42_ef8acb26-64b2-465b-bbab-17930fad9704.png?v=1768664249 Biotech Invention Disclosure Process: Internal Workflows to Capture IP Before It's Lost https://bioxlist.com/blogs/news/prior-art-searches-for-biotech-founders-assessing-patentability-before-filing-provisionals 2026-03-30T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/194_2_5b857f7c-f6b0-4995-8486-9a9e55aa07a4.png?v=1768664448 Prior Art Searches for Biotech Founders: Assessing Patentability Before Filing Provisionals https://bioxlist.com/blogs/news/data-integrity-and-chain-of-custody-in-biotech-linking-lab-results-to-patent-claims 2026-03-31T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/223_1807d2bd-8f09-4fb2-af9d-c8ccd4ebc94c.png?v=1768665088 Data Integrity and Chain of Custody in Biotech: Linking Lab Results to Patent Claims https://bioxlist.com/blogs/news/biotech-trade-secret-vs-patent-strategy-documenting-inventions-while-deciding-protection-routes 2026-04-01T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/116_63b9c6c0-71e3-433c-98bd-fde611fbc91c.png?v=1768665039 Biotech Trade Secret vs Patent Strategy: Documenting Inventions While Deciding Protection Routes https://bioxlist.com/blogs/news/continuation-and-divisional-applications-in-biotech-maximizing-protection-from-provisional-filings 2026-04-02T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/71_052516a7-bc0d-4988-8823-cc9616c0ffc9.png?v=1768665368 Continuation and Divisional Applications in Biotech: Maximizing Protection from Provisional Filings https://bioxlist.com/blogs/news/inventor-declarations-in-biotech-patents-collecting-signed-statements-and-contribution-records 2026-04-03T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/160_fc9cbc9c-b066-412e-901c-6bb518e9c4e8.png?v=1768666641 Inventor Declarations in Biotech Patents: Collecting Signed Statements and Contribution Records https://bioxlist.com/blogs/news/publication-timing-strategy-for-biotech-coordinating-provisional-filings-with-scientific-disclosures 2026-04-06T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/106_2_6d39d15f-687f-4fd7-a5d8-d589b7332c27.png?v=1768667064 Publication Timing Strategy for Biotech: Coordinating Provisional Filings with Scientific Disclosures https://bioxlist.com/blogs/news/nda-templates-for-biotech-founders-mutual-vs-unilateral-agreements-and-when-to-use-each 2026-04-07T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/33_2_30d28aaa-4a7f-4bb7-aa17-05bf92cf1c5e.png?v=1768704809 NDA Templates for Biotech Founders: Mutual vs Unilateral Agreements and When to Use Each https://bioxlist.com/blogs/news/material-transfer-agreements-in-biotech-protecting-your-biological-samples-and-compounds 2026-04-08T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/191_525f3c63-ea72-45ab-a192-7c96e301daca.png?v=1768705141 Material Transfer Agreements in Biotech: Protecting Your Biological Samples and Compounds https://bioxlist.com/blogs/news/biotech-nda-negotiation-red-flags-terms-that-give-away-too-much-control 2026-04-09T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/100_2.png?v=1768705417 Biotech NDA Negotiation Red Flags: Terms That Give Away Too Much Control https://bioxlist.com/blogs/news/mta-standard-clauses-for-biotech-startups-ip-ownership-publication-rights-and-use-restrictions 2026-04-10T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/101_2_b78920a2-597f-4564-aeba-fc3b34c8d4f2.png?v=1768705850 MTA Standard Clauses for Biotech Startups: IP Ownership, Publication Rights, and Use Restrictions https://bioxlist.com/blogs/news/pre-partnership-nda-strategy-in-biotech-disclosing-just-enough-to-evaluate-collaboration 2026-04-13T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/128_2_12f5b50b-8122-49f1-ae4e-d159e8ba1d57.png?v=1768746598 Pre-Partnership NDA Strategy in Biotech: Disclosing Just Enough to Evaluate Collaboration https://bioxlist.com/blogs/news/ubmta-vs-custom-mtas-for-biotech-when-to-use-the-uniform-agreement-and-when-to-customize 2026-04-14T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/157_85dea0c6-cda1-4210-a0ae-64281064622d.png?v=1768916347 UBMTA vs Custom MTAs for Biotech: When to Use the Uniform Agreement and When to Customize https://bioxlist.com/blogs/news/nda-execution-timing-in-biotech-ensuring-protection-before-first-investor-or-partner-meetings 2026-04-15T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/56_f90f9d0f-d2df-48a7-86bf-840a0880f140.png?v=1768916466 NDA Execution Timing in Biotech: Ensuring Protection Before First Investor or Partner Meetings https://bioxlist.com/blogs/news/biotech-mta-recipient-obligations-tracking-use-derivatives-and-third-party-transfers 2026-04-16T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/95_ecdbe698-e883-44cd-8359-f61fb46c8935.png?v=1768916806 Biotech MTA Recipient Obligations: Tracking Use, Derivatives, and Third-Party Transfers https://bioxlist.com/blogs/news/residual-information-clauses-in-biotech-ndas-limiting-what-recipients-can-retain 2026-04-17T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/59_2_8d03056e-2595-4238-bc35-23b2a3bd5d04.png?v=1768922525 Residual Information Clauses in Biotech NDAs: Limiting What Recipients Can Retain https://bioxlist.com/blogs/news/academic-institution-mtas-for-biotech-founders-navigating-university-specific-requirements 2026-04-20T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/94_2_61631bda-e229-491f-a0c2-7db9215fe425.png?v=1768922793 Academic Institution MTAs for Biotech Founders: Navigating University-Specific Requirements https://bioxlist.com/blogs/news/nda-duration-and-survival-terms-in-biotech-setting-appropriate-confidentiality-periods 2026-04-21T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/79_1cf4778e-8fd4-4ff8-8f04-3c30c42d60c9.png?v=1768923087 NDA Duration and Survival Terms in Biotech: Setting Appropriate Confidentiality Periods https://bioxlist.com/blogs/news/return-and-destruction-provisions-in-biotech-mtas-ensuring-materials-dont-persist-indefinitely 2026-04-22T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/144_2_86b75196-9db2-4c42-8c77-b08a0ce57bd8.png?v=1768923486 Return and Destruction Provisions in Biotech MTAs: Ensuring Materials Don't Persist Indefinitely https://bioxlist.com/blogs/news/freedom-to-operate-searches-for-biotech-founders-quick-patent-landscape-assessment-before-launch 2026-04-23T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/173_9b724c9a-e320-4fbe-a8cb-c2874625dde3.png?v=1768923765 Freedom to Operate Searches for Biotech Founders: Quick Patent Landscape Assessment Before Launch https://bioxlist.com/blogs/news/patent-infringement-risk-in-biotech-identifying-blocking-patents-in-your-therapeutic-area 2026-04-24T09:30:05+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/125_2_1eccb7b3-5850-4afb-af46-2d5c11ff5274.png?v=1768923989 Patent Infringement Risk in Biotech: Identifying Blocking Patents in Your Therapeutic Area https://bioxlist.com/blogs/news/fto-opinion-timing-for-biotech-startups-when-to-invest-in-formal-legal-analysis 2026-04-27T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/106_2_613ecfe4-54d6-499c-9d6e-7e03ee969040.png?v=1768924310 FTO Opinion Timing for Biotech Startups: When to Invest in Formal Legal Analysis https://bioxlist.com/blogs/news/biotech-patent-clearance-strategy-balancing-thoroughness-with-early-stage-resource-constraints 2026-04-28T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/195_294cb262-a864-416d-a218-09f027ca64b8.png?v=1768924564 Biotech Patent Clearance Strategy: Balancing Thoroughness with Early-Stage Resource Constraints https://bioxlist.com/blogs/news/public-disclosure-risks-in-biotech-patent-conflict-checks-before-conferences-and-publications 2026-04-29T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/140_d35c569b-fb6d-40d0-bb12-0319419ddb4e.png?v=1768924789 Public Disclosure Risks in Biotech: Patent Conflict Checks Before Conferences and Publications https://bioxlist.com/blogs/news/due-diligence-fto-requirements-for-biotech-fundraising-what-investors-expect-to-see 2026-04-30T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/143_7ec6ce47-47d0-4b66-b226-2fef9365dec9.png?v=1768925492 Due Diligence FTO Requirements for Biotech Fundraising: What Investors Expect to See https://bioxlist.com/blogs/news/competitor-patent-monitoring-in-biotech-setting-up-alerts-for-relevant-issued-and-pending-patents 2026-05-01T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/158_93bba6fa-7eea-4323-9f05-5c52de933025.png?v=1768973227 Competitor Patent Monitoring in Biotech: Setting Up Alerts for Relevant Issued and Pending Patents https://bioxlist.com/blogs/news/method-of-use-patents-in-biotech-assessing-infringement-risk-beyond-composition-claims 2026-05-04T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/154_3680aedb-ddb1-4450-aa83-5f6c8e8ecfd8.png?v=1768973487 Method of Use Patents in Biotech: Assessing Infringement Risk Beyond Composition Claims https://bioxlist.com/blogs/news/patent-expiry-analysis-for-biotech-founders-timing-product-development-around-key-expirations 2026-05-05T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/74_926a9093-8652-449b-90a6-a3f2085566c0.png?v=1768973650 Patent Expiry Analysis for Biotech Founders: Timing Product Development Around Key Expirations https://bioxlist.com/blogs/news/design-around-strategies-in-biotech-modifying-your-approach-to-avoid-patent-infringement 2026-05-06T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/76_6df452e8-15de-47d4-bc88-a49ca34ce85d.png?v=1768973821 Design-Around Strategies in Biotech: Modifying Your Approach to Avoid Patent Infringement https://bioxlist.com/blogs/news/biotech-patent-prosecution-history-review-using-file-wrapper-analysis-to-assess-fto-risks 2026-05-07T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/193_49d34997-4b92-4a65-9018-404b21b1243d.png?v=1768974041 Biotech Patent Prosecution History Review: Using File Wrapper Analysis to Assess FTO Risks https://bioxlist.com/blogs/news/geographic-fto-considerations-for-biotech-prioritizing-patent-searches-by-target-markets 2026-05-08T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/28_f09ae823-9589-4439-a904-dac3eb7fb39e.png?v=1768975145 Geographic FTO Considerations for Biotech: Prioritizing Patent Searches by Target Markets https://bioxlist.com/blogs/news/non-dilutive-funding-landscape-for-biotech-startups-mapping-government-and-foundation-grant-programs 2026-05-11T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/54_8a9a201c-15fc-4c38-8ac2-97487c5b882e.png?v=1768975346 Non-Dilutive Funding Landscape for Biotech Startups: Mapping Government and Foundation Grant Programs https://bioxlist.com/blogs/news/sbir-and-sttr-grants-for-biotech-founders-application-timeline-and-eligibility-requirements 2026-05-12T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/120_697a1b9d-f5cb-4b43-99ae-6b9929328652.png?v=1768975716 SBIR and STTR Grants for Biotech Founders: Application Timeline and Eligibility Requirements https://bioxlist.com/blogs/news/biotech-grant-writing-assignment-strategy-delegating-sections-while-maintaining-scientific-coherence 2026-05-13T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/66_2_c84347e7-e118-4760-9341-4103e46af078.png?v=1768975872 Biotech Grant Writing Assignment Strategy: Delegating Sections While Maintaining Scientific Coherence https://bioxlist.com/blogs/news/reusable-grant-components-for-biotech-building-a-library-of-aims-methods-and-budget-justifications 2026-05-14T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/65_ee3f7e4a-b05c-4ee9-8463-db9aa06d983d.png?v=1768976024 Reusable Grant Components for Biotech: Building a Library of Aims, Methods, and Budget Justifications https://bioxlist.com/blogs/news/disease-specific-foundation-grants-in-biotech-identifying-non-dilutive-funding-by-therapeutic-area 2026-05-15T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/112_7cf08acb-afa4-4f98-abc6-993ea40878a0.png?v=1768976166 Disease-Specific Foundation Grants in Biotech: Identifying Non-Dilutive Funding by Therapeutic Area https://bioxlist.com/blogs/news/grant-application-calendar-management-for-biotech-tracking-deadlines-and-submission-windows 2026-05-18T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/118_2_f62a923a-2d71-4da5-b2c6-14a2cd7c36b0.png?v=1768976424 Grant Application Calendar Management for Biotech: Tracking Deadlines and Submission Windows https://bioxlist.com/blogs/news/nih-funding-mechanisms-for-biotech-companies-r01-r43-r44-and-commercial-applicability 2026-05-19T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/26_4d313caa-a27b-4028-aa5b-452fab7a1bf0.png?v=1768976573 NIH Funding Mechanisms for Biotech Companies: R01, R43, R44 and Commercial Applicability https://bioxlist.com/blogs/news/international-non-dilutive-funding-for-biotech-eu-horizon-eic-accelerator-and-national-programs 2026-05-20T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/170_2_bef0e63b-3aea-4d80-b331-7bb42be52482.png?v=1768976814 International Non-Dilutive Funding for Biotech: EU Horizon, EIC Accelerator, and National Programs https://bioxlist.com/blogs/news/biotech-grant-success-rates-and-roi-calculating-time-investment-vs-award-probability 2026-05-21T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/167_9f97e333-2877-4f04-97e5-24df3806ad4e.png?v=1768977047 Biotech Grant Success Rates and ROI: Calculating Time Investment vs Award Probability https://bioxlist.com/blogs/news/preliminary-data-requirements-for-biotech-grants-generating-feasibility-evidence-on-limited-budgets 2026-05-22T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/66_521a362b-b5e7-4da0-bf3d-81c79a6bc07d.png?v=1768977185 Preliminary Data Requirements for Biotech Grants: Generating Feasibility Evidence on Limited Budgets https://bioxlist.com/blogs/news/collaborative-grant-applications-in-biotech-partnering-with-academic-institutions-for-funding 2026-05-25T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/81.png?v=1768977355 Collaborative Grant Applications in Biotech: Partnering with Academic Institutions for Funding https://bioxlist.com/blogs/news/post-award-grant-management-for-biotech-reporting-requirements-and-milestone-compliance 2026-05-26T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/5_52a633eb-773d-4c31-a148-f7b7dbf950fa.png?v=1768977629 Post-Award Grant Management for Biotech: Reporting Requirements and Milestone Compliance https://bioxlist.com/blogs/news/biotech-consulting-agreements-structuring-ip-assignment-clauses-for-external-r-d-partners 2026-05-27T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/115_d01dc4c1-0a2b-4087-b508-46d1503c123e.png?v=1768977859 Biotech Consulting Agreements: Structuring IP Assignment Clauses for External R&D Partners https://bioxlist.com/blogs/news/scope-of-work-definition-in-biotech-r-d-contracts-preventing-scope-creep-and-misaligned-expectations 2026-05-28T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/19_7f72ec6e-bb7a-4d9f-8429-36a902d675bc.png?v=1768978028 Scope of Work Definition in Biotech R&D Contracts: Preventing Scope Creep and Misaligned Expectations https://bioxlist.com/blogs/news/deliverable-based-payment-structures-for-biotech-cros-milestone-gates-vs-hourly-billing 2026-05-29T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/47_6987f603-bdb8-4c83-ab90-80ad4738a81e.png?v=1768978224 Deliverable-Based Payment Structures for Biotech CROs: Milestone Gates vs Hourly Billing https://bioxlist.com/blogs/news/background-ip-protection-in-biotech-consulting-agreements-excluding-pre-existing-know-how 2026-06-01T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/47_2_a3b4a816-4386-4465-abc2-7cb6f8f7215f.png?v=1768978461 Background IP Protection in Biotech Consulting Agreements: Excluding Pre-Existing Know-How https://bioxlist.com/blogs/news/confidentiality-and-publication-rights-in-biotech-r-d-contracts-balancing-disclosure-with-protection 2026-06-02T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/77_fabeb1b3-4814-4e7d-bd08-b4f6cc00e680.png?v=1768978659 Confidentiality and Publication Rights in Biotech R&D Contracts: Balancing Disclosure with Protection https://bioxlist.com/blogs/news/biotech-service-provider-indemnification-liability-allocation-for-failed-experiments-and-data-issues 2026-06-03T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/34_9e48ee76-2edd-4efb-8de1-24d4fd956d0d.png?v=1768979132 Biotech Service Provider Indemnification: Liability Allocation for Failed Experiments and Data Issues https://bioxlist.com/blogs/news/change-order-mechanisms-for-biotech-r-d-contracts-managing-protocol-modifications-mid-project 2026-06-04T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/94_b1234178-a931-4ad3-93a8-3ba44b3f16f4.png?v=1768979640 Change Order Mechanisms for Biotech R&D Contracts: Managing Protocol Modifications Mid-Project https://bioxlist.com/blogs/news/quality-control-and-data-ownership-in-biotech-cro-agreements-ensuring-standards-and-access-rights 2026-06-05T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/118.png?v=1768979928 Quality Control and Data Ownership in Biotech CRO Agreements: Ensuring Standards and Access Rights https://bioxlist.com/blogs/news/termination-provisions-for-biotech-consulting-contracts-exit-strategies-and-work-product-handover 2026-06-08T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/138_256e54f2-6edd-4d3e-8972-9fcf7e1d1733.png?v=1768980126 Termination Provisions for Biotech Consulting Contracts: Exit Strategies and Work Product Handover https://bioxlist.com/blogs/news/subcontracting-restrictions-in-biotech-r-d-agreements-controlling-third-party-involvement 2026-06-09T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/164_4685644a-7afb-492a-8cf6-8a1bf4eae9c5.png?v=1768980301 Subcontracting Restrictions in Biotech R&D Agreements: Controlling Third-Party Involvement https://bioxlist.com/blogs/news/performance-metrics-and-acceptance-criteria-for-biotech-deliverables-defining-quality-standards-upfront 2026-06-10T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/105_33e8fde9-ce7a-403c-ba33-1428b3384f17.png?v=1768980511 Performance Metrics and Acceptance Criteria for Biotech Deliverables: Defining Quality Standards Upfront https://bioxlist.com/blogs/news/dispute-resolution-clauses-in-biotech-r-d-contracts-arbitration-vs-litigation-for-scientific-disagreements 2026-06-11T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/40_eb550d50-d828-4c97-8b91-06634c862a3b.png?v=1768980906 Dispute Resolution Clauses in Biotech R&D Contracts: Arbitration vs Litigation for Scientific Disagreements https://bioxlist.com/blogs/news/employee-vs-contractor-classification-in-biotech-legal-distinctions-and-compliance-risks 2026-06-12T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/31_7ac492b0-3648-44ea-a1b0-fa5bed9f0058.png?v=1768981090 Employee vs Contractor Classification in Biotech: Legal Distinctions and Compliance Risks https://bioxlist.com/blogs/news/equity-compensation-design-for-biotech-early-hires-strike-prices-vesting-and-option-percentages 2026-06-15T21:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/23_df5e553b-859e-45a3-863e-040df1875f66.png?v=1768981286 Equity Compensation Design for Biotech Early Hires: Strike Prices, Vesting, and Option Percentages https://bioxlist.com/blogs/news/ip-assignment-clauses-in-biotech-employment-contracts-protecting-company-inventions-from-day-one 2026-06-16T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/53_b40a7b61-e0ca-40d7-a251-e27bfb6c66fe.png?v=1768981676 IP Assignment Clauses in Biotech Employment Contracts: Protecting Company Inventions from Day One https://bioxlist.com/blogs/news/work-authorization-verification-for-biotech-startups-i-9-compliance-and-visa-sponsorship-considerations 2026-06-17T09:30:03+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/197_5d1f05c0-ae00-4f72-a529-e6658bc81b83.png?v=1768981936 Work Authorization Verification for Biotech Startups: I-9 Compliance and Visa Sponsorship Considerations https://bioxlist.com/blogs/news/at-will-employment-in-biotech-drafting-offer-letters-without-implied-contract-obligations 2026-06-18T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/198_f44b9ec7-bf29-430f-832b-180beba2e39c.png?v=1768983338 At-Will Employment in Biotech: Drafting Offer Letters Without Implied Contract Obligations https://bioxlist.com/blogs/news/non-compete-and-non-solicitation-clauses-for-biotech-employees-state-by-state-enforceability 2026-06-19T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/81_2_c6a43e96-8f17-40a7-b569-e18eb292baa4.png?v=1768983497 Non-Compete and Non-Solicitation Clauses for Biotech Employees: State-by-State Enforceability https://bioxlist.com/blogs/news/equity-offer-negotiation-in-biotech-hiring-balancing-cash-constraints-with-competitive-packages 2026-06-22T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/83.png?v=1768983647 Equity Offer Negotiation in Biotech Hiring: Balancing Cash Constraints with Competitive Packages https://bioxlist.com/blogs/news/probationary-periods-and-performance-evaluations-in-biotech-early-exit-strategies-for-bad-hires 2026-06-23T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/132_c9f018a3-b92d-4dda-bfd1-8960ff40f18b.png?v=1768983799 Probationary Periods and Performance Evaluations in Biotech: Early Exit Strategies for Bad Hires https://bioxlist.com/blogs/news/benefits-and-perks-for-early-biotech-employees-healthcare-pto-and-laboratory-safety-requirements 2026-06-24T09:30:04+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/131.png?v=1768984319 Benefits and Perks for Early Biotech Employees: Healthcare, PTO, and Laboratory Safety Requirements https://bioxlist.com/blogs/news/independent-contractor-agreements-in-biotech-irs-classification-tests-and-misclassification-penalties 2026-06-25T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/84.png?v=1768984291 Independent Contractor Agreements in Biotech: IRS Classification Tests and Misclassification Penalties https://bioxlist.com/blogs/news/scientific-advisory-board-vs-employee-roles-in-biotech-structuring-relationships-with-academic-experts 2026-06-26T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/18_eac9629e-6d38-477c-b346-dfc7544f2fa4.png?v=1768984503 Scientific Advisory Board vs Employee Roles in Biotech: Structuring Relationships with Academic Experts https://bioxlist.com/blogs/news/background-checks-and-reference-verification-for-biotech-hires-protecting-against-resume-fraud 2026-06-29T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/25_5359301d-1e45-474e-848f-ccea2546ca51.png?v=1768985070 Background Checks and Reference Verification for Biotech Hires: Protecting Against Resume Fraud https://bioxlist.com/blogs/news/biotech-advisor-equity-benchmarks-allocating-0-1-1-based-on-contribution-and-stage 2026-06-30T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/153_8011b496-e7bb-4fe6-bece-e5209359deb5.png?v=1768985277 Biotech Advisor Equity Benchmarks: Allocating 0.1–1% Based on Contribution and Stage https://bioxlist.com/blogs/news/advisor-agreement-essentials-for-biotech-startups-term-length-termination-and-renewal-provisions 2026-07-01T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/163_a778e5c9-c857-4513-b363-d3049fea2217.png?v=1768985425 Advisor Agreement Essentials for Biotech Startups: Term Length, Termination, and Renewal Provisions https://bioxlist.com/blogs/news/defining-advisor-deliverables-in-biotech-setting-clear-expectations-beyond-general-guidance 2026-07-02T09:30:01+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/146_2_5d6bf1f5-0d40-4218-b765-6b153e3e5ec6.png?v=1768985622 Defining Advisor Deliverables in Biotech: Setting Clear Expectations Beyond General Guidance https://bioxlist.com/blogs/news/vesting-schedules-for-biotech-advisors-monthly-vs-quarterly-accrual-over-2-4-year-terms 2026-07-03T09:30:02+02:00 weekly https://cdn.shopify.com/s/files/1/0899/5658/1700/articles/62_bd2b0c4e-fa49-4082-b1bd-e38dab979e61.png?v=1768985787 Vesting Schedules for Biotech Advisors: Monthly vs Quarterly Accrual Over 2-4 Year Terms